Content type:,Referral,Output automatically generated from content on www.ema.europa.eu on:,22/03/2025 - 02:00,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
Category,Referral name,International non-proprietary name (INN) / common name,Current status,Safety referral?,Referral type,Associated names (centrally authorised medicines),Associated names (non-centrally authorised medicines),Class,Reference number,Non-PRAC decision making model,PRAC decision making model,Authorisation model,PRAC recommendation,Procedure start date,PRAC recommendation date,CMDh position date,CHMP/CVMP opinion date,European Commission decision date,First published date,Last updated date,Referral URL
Human,Azithromycin-containing medicinal products for systemic use,azithromycin,Under evaluation,No,Article 31 referrals,,,Macrolides,EMEA/H/A-31/1532,,,Nationally authorised product(s),,,,,,,10/11/2023,05/03/2025,https://www.ema.europa.eu/en/medicines/human/referrals/azithromycin-containing-medicinal-products-systemic-use
Human,Finasteride- and dutasteride-containing medicinal products,finasteride;dutasteride,Under evaluation,Yes,Article 31 referrals,,,genito-urinary system and sex hormones; dermatologicals,EMEA/H/A-31/1539,,PRAC-CMDh,Nationally authorised product(s),,03/10/2024,,,,,04/10/2024,18/02/2025,https://www.ema.europa.eu/en/medicines/human/referrals/finasteride-dutasteride-containing-medicinal-products
Human,Metamizole-containing medicinal products,metamizole,European Commission final decision,Yes,Article 107i procedures,,,,EMEA/H/A-107i/1537,,PRAC-CMDh,Nationally authorised product(s),,13/06/2024,05/09/2024,18/09/2024,,22/11/2024,14/06/2024,29/01/2025,https://www.ema.europa.eu/en/medicines/human/referrals/metamizole-containing-medicinal-products-0
Human,Ocaliva,obeticholic acid,European Commission final decision,No,Article 20 procedures,Ocaliva,,Bile acids and derivatives,EMEA/H/A-20/1531/C/004093/0045,CHMP-EC,,Centrally authorised product(s),,,,,27/06/2024,30/08/2024,13/10/2023,07/01/2025,https://www.ema.europa.eu/en/medicines/human/referrals/ocaliva
Human,Mysimba,naltrexone;bupropion,Under evaluation,No,Article 20 procedures,Mysimba,,,EMEA/H/A-20/1530/C/3687/0065,CHMP-EC,,Centrally authorised product(s),,,,,,,15/09/2023,06/01/2025,https://www.ema.europa.eu/en/medicines/human/referrals/mysimba
Human,Oxbryta,Voxelotor,Under evaluation,No,Article 20 procedures,Oxbryta,,Haemoglobin S (HbS) polymerization inhibitor,EMEA/H/A-20/1538/C/004869/0014,,,Centrally authorised product(s),,,,,,,30/07/2024,17/12/2024,https://www.ema.europa.eu/en/medicines/human/referrals/oxbryta
Human,"Lorazepam Macure 4 mg/ml, solution for injection",lorazepam,European Commission final decision,No,Article 13 referrals,,,,EMEA/H/A-13/1536,CHMP-EC,,Nationally authorised product(s),,22/02/2024,,,27/06/2024,29/08/2024,28/06/2024,08/10/2024,https://www.ema.europa.eu/en/medicines/human/referrals/lorazepam-macure-4-mg-ml-solution-injection
Human,Havrix,"hepatitis A virus (inactivated, adsorbed)",European Commission final decision,No,Article 30 referrals,,Havrix and associated names,,EMEA/H/A-30/1527,CHMP-EC,,Nationally authorised product(s),,,,,27/06/2024,26/08/2024,15/09/2023,04/09/2024,https://www.ema.europa.eu/en/medicines/human/referrals/havrix
Human,Hydroxyprogesterone caproate-containing medicinal products,hydroxyprogesterone caproate,CMDh final position,Yes,Article 31 referrals,,Lentogest  ;Progesterone Retard Pharlon  ;Proluton Depot,progestogens,EMEA-H-A-31-1528,,PRAC-CMDh,Nationally authorised product(s),Suspension,12/05/2023,16/05/2024,26/06/2024,,,12/05/2023,05/07/2024,https://www.ema.europa.eu/en/medicines/human/referrals/hydroxyprogesterone-caproate-containing-medicinal-products
Human,Micrazym and associated names,porcine pancreas enzymes,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29(4)/1535,CHMP-EC,,Nationally authorised product(s),,,,,21/03/2024,16/05/2024,22/03/2024,11/06/2024,https://www.ema.europa.eu/en/medicines/human/referrals/micrazym-associated-names
Human,Synapse,,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1529,CHMP-EC,,Nationally authorised product(s),,,,,21/03/2024,24/05/2024,21/07/2023,05/06/2024,https://www.ema.europa.eu/en/medicines/human/referrals/synapse
Human,Ibuprofen NVT,ibuprofen,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29(4)/1533,,,Nationally authorised product(s),,,,,22/02/2024,10/05/2024,23/02/2024,05/06/2024,https://www.ema.europa.eu/en/medicines/human/referrals/ibuprofen-nvt
Veterinary,Kexxtone 32.4 g continuous-release intraruminal device for cattle,monensin,European Commission final decision,No,,Kexxtone,,,EMEA/V/A/150,,,Centrally authorised product(s),,14/03/2024,,,23/04/2024,15/05/2024,04/06/2024,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/kexxtone-324-g-continuous-release-intraruminal-device-cattle
Veterinary,Procaine benzylpenicillin,,European Commission final decision,No,,,,,EMEA/V/A/145,,,Nationally authorised product(s),,16/02/2022,,,07/09/2023,11/12/2023,23/02/2022,29/05/2024,https://www.ema.europa.eu/en/medicines/veterinary/referrals/procaine-benzylpenicillin
Human,Pseudoephedrine-containing medicinal products,pseudoephedrine,European Commission final decision,Yes,Article 31 referrals,Aerinaze,,Nasal decongestants for systemic use,EMEA/H/A-31/1526,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),,09/02/2023,30/11/2023,,25/01/2024,27/03/2024,10/02/2023,04/04/2024,https://www.ema.europa.eu/en/medicines/human/referrals/pseudoephedrine-containing-medicinal-products
Veterinary,Veterinary medicinal products containing N-methyl pyrrolidone as an excipient,,European Commission final decision,No,,Vectra 3D;Melovem,,,EMEA/V/A/146,,,Centrally and nationally authorised products (mixed),,,,,08/12/2022,28/03/2023,18/05/2022,22/03/2024,https://www.ema.europa.eu/en/medicines/veterinary/referrals/veterinary-medicinal-products-containing-n-methyl-pyrrolidone-excipient
Human,Topiramate,topiramate,CMDh final position,No,Article 31 referrals,,,,EMEA/H/A-31/1520,,PRAC-CMDh,Nationally authorised product(s),,01/09/2022,31/08/2023,10/11/2023,,,02/09/2022,23/11/2023,https://www.ema.europa.eu/en/medicines/human/referrals/topiramate
Human,Adakveo,crizanlizumab,European Commission final decision,No,Article 20 procedures,Adakveo,,Other haematological agents,EMEA/H/A-20/1525/C/4874/0013,CHMP-EC,,Centrally authorised product(s),,26/01/2023,,,25/05/2023,03/08/2023,27/01/2023,29/08/2023,https://www.ema.europa.eu/en/medicines/human/referrals/adakveo
Human,Quinolone- and fluoroquinolone-containing medicinal products,nalidixic acid;pipemidic acid;cinoxacin;enoxacin;pefloxacin;lomefloxacin;ciprofloxacin;levofloxacin;ofloxacin;moxifloxacin;norfloxacin;prulifloxacin;rufloxacin;flumequin,European Commission final decision,Yes,Article 31 referrals,Quinsair,,Quinolones and fluoroquinolones,EMEA/H/A-31/1452,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),Risk minimisation measures,09/02/2017,04/10/2018,,15/11/2018,11/03/2019,10/02/2017,08/06/2023,https://www.ema.europa.eu/en/medicines/human/referrals/quinolone-fluoroquinolone-containing-medicinal-products
Human,Janus kinase inhibitors (JAKi),tofacitinib;abrocitinib;baricitinib;upadacitinib;filgotinib,European Commission final decision,Yes,Article 20 procedures,Xeljanz;Cibinqo;Olumiant;Rinvoq;Jyseleca;Xeljanz,,,EMEA/H-A20/1517/C/004214/0048; EMEA/H-A20/1517/C/005452/0003; EMEA/H-A20/1517/C/004085/0032; EMEA/H-A20/1517/C/004760/0017; EMEA/H-A20/1517/C/005113/0014,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,10/02/2022,12/01/2023,,23/01/2023,10/03/2023,11/02/2022,22/05/2023,https://www.ema.europa.eu/en/medicines/human/referrals/janus-kinase-inhibitors-jaki
Veterinary,"Catophos 100 mg/ml+0.05 mg/ml solution for injection for horses, cattle, dogs and cats and associated names",Butafosfan;Cyanocobalamin,European Commission final decision,No,,,,,EMEA/V/A/147,,,Nationally authorised product(s),,,,,15/02/2023,03/04/2023,25/04/2023,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/catophos-100-mg-ml005-mg-ml-solution-injection-horses-cattle-dogs-and-cats-and-associated-names
Veterinary,"Vey Tosal 100 mg/ml + 0.05 mg/ml solution for injection for horses, cattle, dogs and cats and associated names",Butafosfan;Cyanocobalamin,European Commission final decision,No,,,,,EMEA/V/A/148,,,Nationally authorised product(s),,,,,15/02/2023,03/04/2023,25/04/2023,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/vey-tosal-100-mg-ml-005-mg-ml-solution-injection-horses-cattle-dogs-and-cats-and-associated-names
Human,Pholcodine-containing medicinal products,pholcodine,European Commission final decision,Yes,Article 107i procedures,,,Cough and cold preparations,EMEA/H/A-107i/1521,,PRAC-CMDh,Nationally authorised product(s),Revocation,01/09/2022,01/12/2022,14/12/2022,,06/03/2023,02/09/2022,29/03/2023,https://www.ema.europa.eu/en/medicines/human/referrals/pholcodine-containing-medicinal-products
Human,Gelisia and associated names,timolol maleate,European Commission final decision,No,Article 29(4) referrals,,Genoptol  ;Gelisia  ;Timolol sifi 1 mg/g gel oftalmico,,EMEA/H/A-29(4)/1522,CHMP-EC,,Nationally authorised product(s),,,,,15/12/2022,27/02/2023,16/12/2022,16/03/2023,https://www.ema.europa.eu/en/medicines/human/referrals/gelisia-and-associated-names
Human,Rambis and associated names,ramipril;bisoprolol fumarate,European Commission final decision,No,Article 29(4) referrals,,Ralbior,,EMEA/H/A-29(4)/1519,CHMP-EC,,Nationally authorised product(s),,,,,15/12/2022,15/02/2023,16/12/2022,08/03/2023,https://www.ema.europa.eu/en/medicines/human/referrals/rambis-and-associated-names
Human,Amfepramone-containing medicinal products,amfepramone,European Commission final decision,Yes,Article 31 referrals,,Regenon  ;Tenuate Retard  ;Amfepramon-Hormosan  ;Regenon Retard,,EMEA/H/A-31/1501,,PRAC-CMDh,Nationally authorised product(s),Revocation,11/02/2021,27/10/2022,10/11/2022,,13/01/2023,12/02/2021,20/01/2023,https://www.ema.europa.eu/en/medicines/human/referrals/amfepramone-containing-medicinal-products
Human,Synchron,,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1515,CHMP-EC,,Nationally authorised product(s),,,,,19/05/2022,28/11/2022,28/01/2022,16/12/2022,https://www.ema.europa.eu/en/medicines/human/referrals/synchron
Human,Nomegestrol and chlormadinone,nomegestrol;chlormadinone,European Commission final decision,No,Article 31 referrals,Zoely,,,EMEA/H/A-31/1510,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),Risk minimisation measures,30/09/2021,07/07/2022,,01/09/2022,28/11/2022,01/10/2021,14/12/2022,https://www.ema.europa.eu/en/medicines/human/referrals/nomegestrol-chlormadinone
Veterinary,Veterinary medicinal products containing toltrazuril to be administered orally to chickens,toltrazuril,European Commission final decision,No,,,,,EMEA/V/A/144,,,Nationally authorised product(s),,,,,14/07/2022,09/11/2022,14/12/2022,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/veterinary-medicinal-products-containing-toltrazuril-be-administered-orally-chickens
Human,Terlipressin-containing medicinal products indicated in the treatment of hepatorenal syndrome,terlipressin,CMDh final position,No,Article 31 referrals,,,vasopressin and analogues,EMEA/H/A-31/1514,,PRAC-CMDh,Nationally authorised product(s),,13/01/2022,29/09/2022,10/11/2022,,,21/02/2022,22/11/2022,https://www.ema.europa.eu/en/medicines/human/referrals/terlipressin-containing-medicinal-products-indicated-treatment-hepatorenal-syndrome
Human,Rubraca,rucaparib,European Commission final decision,Yes,Article 20 procedures,Rubraca,,Other antineoplastic agents,EMEA/H/A-20/1518/C/4272/0033,CHMP-EC,,Centrally authorised product(s),,22/04/2022,,,21/07/2022,21/09/2022,22/04/2022,17/10/2022,https://www.ema.europa.eu/en/medicines/human/referrals/rubraca
Human,Daruph and Anafezyn,dasatinib (anhydrous),European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29(4)/1516,CHMP-EC,,Nationally authorised product(s),,,,,19/05/2022,18/07/2022,20/05/2022,09/08/2022,https://www.ema.europa.eu/en/medicines/human/referrals/daruph-and-anafezyn
Human,Zynteglo,betibeglogene autotemcel,European Commission final decision,No,Article 20 procedures,Zynteglo,,Haematological agents,EMEA/H/A-20/1504/C/003691/0023,,PRAC-CAT-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,11/03/2021,09/07/2021,,22/07/2021,16/09/2021,12/03/2021,08/07/2022,https://www.ema.europa.eu/en/medicines/human/referrals/zynteglo
Human,Nasolam and associated names,midazolam,European Commission final decision,No,Article 29(4) referrals,,,Hypnotics and sedatives (benzodiazepine derivatives),EMEA/H/A-29(4)/1511,CHMP-EC,,Nationally authorised product(s),,,,,27/01/2022,01/04/2022,28/01/2022,29/04/2022,https://www.ema.europa.eu/en/medicines/human/referrals/nasolam-and-associated-names
Human,Lidocain/Prilocain Idetec and associated names,lidocaine;prilocaine,European Commission final decision,No,Article 29(4) referrals,,"Lidocaïne / Prilocaïne 5% Focus, Crème",,EMEA/H/A-29(4)/1506,CHMP-EC,,Nationally authorised product(s),,,,,14/10/2021,,15/10/2021,21/04/2022,https://www.ema.europa.eu/en/medicines/human/referrals/lidocain-prilocain-idetec-associated-names
Human,Etifoxine-containing medicinal products,etifoxine,European Commission final decision,No,Article 31 referrals,,Stresam,Non-benzodiazepine anxiolytic,EMEA/H/A-31/1509,CHMP-EC,,Nationally authorised product(s),,,,,24/06/2021,24/03/2022,25/06/2021,21/04/2022,https://www.ema.europa.eu/en/medicines/human/referrals/etifoxine-containing-medicinal-products
Human,Hydroxyethyl starch (HES) containing medicinal products,hydroxyethyl starch,European Commission final decision,Yes,Article 107i procedures,,,,EMEA/H/A-107i/1457,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,26/10/2017,12/01/2018,26/10/2017,,17/07/2018,27/10/2017,11/02/2022,https://www.ema.europa.eu/en/medicines/human/referrals/hydroxyethyl-starch-hes-containing-medicinal-products
Veterinary,Injectable veterinary medicinal products containing vitamin A for use in food producing species,Vitamin A (retinol and its esters),European Commission final decision,No,,,,,EMEA/V/A/141,,,Nationally authorised product(s),,,,,12/05/2021,18/08/2021,27/09/2021,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/injectable-veterinary-medicinal-products-containing-vitamin-use-food-producing-species
Veterinary,Ronaxan and its associated names,Doxycycline,European Commission final decision,No,,,,,EMEA/V/A/135,,,Nationally authorised product(s),,,,,17/06/2021,30/08/2021,27/09/2021,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/ronaxan-and-its-associated-names
Human,Intravenous iron-containing medicinal products,ferric carboxymaltose;iron dextran;sodium ferric gluconate;iron isomaltoside;iron sucrose,European Commission final decision,No,Article 31 referrals,,,-,EMEA/H/A-31/1322,CHMP-EC,,,,,,,27/06/2013,13/09/2013,28/06/2013,28/07/2021,https://www.ema.europa.eu/en/medicines/human/referrals/intravenous-iron-containing-medicinal-products
Veterinary,Modified live porcine respiratory and reproductive syndrome (PRRS) virus vaccines,Porcine respiratory and reproductive syndrome virus vaccine (live),European Commission final decision,No,,,,,EMEA-V-A-142,,,,,,,,15/04/2021,13/07/2021,28/07/2021,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/modified-live-porcine-respiratory-and-reproductive-syndrome-prrs-virus-vaccines
Human,Ifosfamide solutions,ifosfamide,European Commission final decision,Yes,Article 31 referrals,,Ifosfamide Eg  ;Ifo-Cell  ;Ifo-Cell N  ;Ifo-Cell N 2000,alkylating agent,EMEA/H/A-31/1495,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,12/03/2020,11/03/2021,21/04/2021,,21/06/2021,12/03/2020,19/07/2021,https://www.ema.europa.eu/en/medicines/human/referrals/ifosfamide-solutions
Human,Varilrix,live attenuated varicella virus (OKA strain),European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1499,,,Nationally authorised product(s),,,,,25/02/2021,21/04/2021,26/06/2020,09/06/2021,https://www.ema.europa.eu/en/medicines/human/referrals/varilrix
Veterinary,Adjusol trimethoprim sulfa liquide and its associated names,,European Commission final decision,No,,,,,EMEA/V/A/134,,,Nationally authorised product(s),,,,,10/12/2020,25/02/2021,19/03/2021,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/adjusol-trimethoprim-sulfa-liquide-and-its-associated-names
Human,Angiotensin-II-receptor antagonists (sartans) containing a tetrazole group,valsartan;candesartan;irbesartan;losartan;olmesartan,European Commission final decision,Yes,Article 31 referrals,Karvezide;Karvea;Irbesartan/Hydrochlorothiazide Teva;Irbesartan Zentiva (previously Irbesartan Winthrop);Irbesartan Teva;Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop);Ifirmasta (previously Irbesartan Krka);Ifirmacombi;Aprovel;Neparvis;Exforge;Exforge HCT;Entresto;Dafiro HCT;Dafiro;Copalia HCT;Copalia;Amlodipine  / Valsartan Mylan;CoAprovel,,angiotensin-II-receptor antagonist,EMEA/H/A-31/1471,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),,,,,12/11/2020,19/02/2021,17/07/2018,19/03/2021,https://www.ema.europa.eu/en/medicines/human/referrals/angiotensin-ii-receptor-antagonists-sartans-containing-tetrazole-group
Veterinary,"Valbazen 100 mg/ml Total Spectrum Wormer oral suspension and associated names, including its generic/hybrid products",albendazole,European Commission final decision,No,,,,,EMEA-V-A-140,,,Centrally and nationally authorised products (mixed),,,,,05/11/2020,18/01/2021,22/02/2021,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/valbazen-100-mg-ml-total-spectrum-wormer-oral-suspension-and-associated-names-including-its-generic-hybrid-products
Human,Ranitidine-containing medicinal products,ranitidine,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1491,CHMP-EC,,Nationally authorised product(s),,,,,17/09/2020,24/11/2020,26/06/2020,17/02/2021,https://www.ema.europa.eu/en/medicines/human/referrals/ranitidine-containing-medicinal-products
Veterinary,Tiamulin hydrogen fumarate presented as premix for medicated feeding stuff and oral powder for in-feed use to be administered to pigs,tiamulin hydrogen fumarate,European Commission final decision,No,,,,,EMEA/V/A/137,,,,,,,,09/09/2020,09/12/2020,05/02/2021,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/tiamulin-hydrogen-fumarate-presented-premix-medicated-feeding-stuff-oral-powder-feed-use-be-administered-pigs
Human,Ulipristal acetate 5mg medicinal products,ulipristal acetate,European Commission final decision,Yes,Article 31 referrals,Esmya;Ulipristal Acetate Gedeon Richter,,Progesterone receptor modulators,EMEA/H/A-31/1496,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),,12/03/2020,04/09/2020,,12/11/2020,11/01/2021,13/03/2020,03/02/2021,https://www.ema.europa.eu/en/medicines/human/referrals/ulipristal-acetate-5mg-medicinal-products
Human,Picato,ingenol mebutate,European Commission final decision,Yes,Article 20 procedures,Picato,,,EMEA/H/A-20/1489/C/002275/0030,,PRAC-CHMP-EC,Centrally authorised product(s),Suspension,05/09/2019,17/04/2020,,30/04/2020,06/07/2020,06/09/2019,16/11/2020,https://www.ema.europa.eu/en/medicines/human/referrals/picato
Veterinary,"Betamox LA 150 mg/ml suspension for injection and associated names, and generics products thereof",Amoxicillin trihydrate,European Commission final decision,No,,,Stresnil,,EMEA/V/A/132,,,Nationally authorised product(s),,,,,16/07/2020,12/10/2020,12/11/2020,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/betamox-la-150-mg-ml-suspension-injection-and-associated-names-and-generics-products-thereof
Veterinary,"Stresnil 40 mg/ml solution for injection for pigs and associated names, and generic products thereof",azaperone,European Commission final decision,No,,,Stresnil,,EMEA/V/A/138,,,Nationally authorised product(s),,,,,16/07/2020,12/10/2020,30/10/2020,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/stresnil-40-mg-ml-solution-injection-pigs-associated-names-generic-products-thereof
Human,Ibuprofen Kabi 400 mg Infusionslösung and associated names,ibuprofen,European Commission final decision,No,Article 29(4) referrals,,Ibuprofen Fresenius Kabi 400 mg oplossing voor infusie  ;Ibuprofen Fresenius Kabi 400 mg solution pour perfusion  ;Ibuprofen Kabi  ;Ibuprofen Kabi 400 mg oldatos infúzió  ;Ibuprofen Kabi 400 mg soluţie perfuzabilă  ;Ibuprofen Kabi 400 mg  ;Ibuprofen Kabi 400 mg raztopina za infundiranje  ;Ibuprofeno Kabi 400 mg solución para perfusion  ;Ibuprofen Kabi 400 mg Solution for Infusion,,EMEA/H/A-29(4)/1498,,,Nationally authorised product(s),,,,,23/07/2020,15/10/2020,24/07/2020,26/10/2020,https://www.ema.europa.eu/en/medicines/human/referrals/ibuprofen-kabi-400-mg-infusionslosung-and-associated-names
Human,Panexcell,atazanavir;atazanavir sulfate;Amoxicillin trihydrate;iron sucrose;amoxicillin;azithromycin dihydrate;carbocisteine;trimethoprim,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1494,,,Nationally authorised product(s),,,,,27/02/2020,24/09/2020,28/02/2020,22/10/2020,https://www.ema.europa.eu/en/medicines/human/referrals/panexcell
Human,Yondelis,trabectedin,European Commission final decision,Yes,Article 20 procedures,Yondelis,,Antineoplastic agents,EMEA/H/A-20/1493/C/0773/0060,,,Centrally authorised product(s),,,,,24/07/2020,24/09/2020,28/02/2020,09/10/2020,https://www.ema.europa.eu/en/medicines/human/referrals/yondelis
Veterinary,"Dinolytic 12.5 mg/ml and 5 mg/ml solutions for injection and associated names, and generic products thereof",dinoprost,European Commission final decision,No,,,,,EMEA-V-A-136,,,,,,,,18/06/2020,16/09/2020,06/10/2020,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/dinolytic-125-mg-ml-5-mg-ml-solutions-injection-associated-names-generic-products-thereof
Human,Budesonide SUN,budesonide,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29(4)/1492,,,Nationally authorised product(s),,,,,25/06/2020,19/08/2020,27/03/2020,16/09/2020,https://www.ema.europa.eu/en/medicines/human/referrals/budesonide-sun
Human,Leuprorelin-containing depot medicinal products,leuprorelin,CMDh final position,Yes,Article 31 referrals,,Daronda  ;Depo-Eligard  ;Eligard  ;Eligard Depot  ;Eligard Mensua  ;Eligard Semestral  ;Eligard Trimestral  ;Elityran 1 Month Depot (Dps)  ;Elityran 3 Month Depot (Dps)  ;Enanton Depot Dual  ;Enanton Depot Set  ;Enantone  ;Enantone L.P  ;Enantone Lp  ;Enantone Monats-Depot  ;Ginecrin Depot  ;Klebrocid 3-Monats-Depot  ;Klebrocid Depot Zweikammerspritze  ;Leptoprol  ;Lerin  ;Leugon  ;Leuprex 3  ;Leuprol  ;Leuprolin Ratiopharm  ;Leuprone 1-Monatsdepot  ;Leuprone 3-Monatsdepot  ;Leuprorelin 1-Month Depot Gp-Pharm  ;Leuprorelin Hexal  ;Leuprorelin Sandoz  ;Leuprorelina Gp-Pharm  ;Leupro-Sandoz 1-Monats-Depot  ;Leupro-Sandoz 3-Monats-Depot  ;Leuprorelina Trimestral Sandoz  ;Leuprostin  ;Leuproreline Sandoz  ;Lucrin  ;Lucrin Depot  ;Lucrin Pds Depot  ;Lucrin Pds Depot 1 Maand  ;Lucrin Pds Depot 3 Maanden  ;Lucrin Pds Depot 6 Maanden  ;Lupron Depo  ;Lutrate 1 Month Depot  ;Lutrate 3 Month Depot  ;Lutrate Depo  ;Lutrate Depot  ;Lutrate Depot Trimestral  ;Politrate  ;Politrate Depot  ;Procren Depot  ;Procren Depot Pds  ;Procrin Mensual  ;Procrin Semestral  ;Procrin Trimestral  ;Prostap 3 Dcs  ;Prostap 6 Dcs  ;Prostap Sr Dcs  ;Prostaplant  ;Sixantone  ;Trenantone  ;Trenantone-Gyn  ;Zeulide  ;Елигард  ;Лутрат Депо,,EMEA/H/A-31/1486,,PRAC-CMDh,Nationally authorised product(s),,,14/05/2020,25/06/2020,,,14/06/2019,31/07/2020,https://www.ema.europa.eu/en/medicines/human/referrals/leuprorelin-containing-depot-medicinal-products
Human,"Fluorouracil and fluorouracil related substances (capecitabine, tegafur and flucytosine) containing medicinal products",capecitabine;fluorouracil;tegafur;flucytosine,European Commission final decision,Yes,Article 31 referrals,Xeloda;Teysuno;Capecitabine Accord;Capecitabine Medac;Capecitabine Teva;Ecansya (previously Capecitabine Krka),,,EMEA/H/A-31/1481,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),Variation,15/03/2019,12/03/2020,,30/04/2020,07/07/2020,15/03/2019,23/07/2020,https://www.ema.europa.eu/en/medicines/human/referrals/fluorouracil-fluorouracil-related-substances-capecitabine-tegafur-flucytosine-containing-medicinal-products
Human,Carbamazepin Tillomed,carbamazepin,European Commission final decision,Yes,Article 29(4) referrals,,Carbamazepin Tillomed  ;Carbamazepina Tillomed  ;Karbamazepin Tillomed  ;Karbamazepina Tillomed,,EMEA/H/A-29(4)/1497,,,Nationally authorised product(s),,,,,30/04/2020,25/06/2020,30/04/2020,21/07/2020,https://www.ema.europa.eu/en/medicines/human/referrals/carbamazepin-tillomed
Human,Fosfomycin-containing medicinal products,fosfomycin calcium;fosfomycin disodium;fosfomycin sodium;fosfomycin trometamol,European Commission final decision,Yes,Article 31 referrals,,Afastural  ;Berny Adulti  ;Danifos Adulti  ;Fomicyt  ;Fosfocin  ;Fosfocina  ;Fosfocine  ;Fosfopharm  ;Fosfuro  ;Fosmol  ;Fostrofemge  ;Gynofostrome  ;Infectofos  ;Infeur Adulti  ;Interfos  ;Monural  ;Monuril  ;Monurol  ;Rapidnorm  ;Solufos  ;Symural  ;Uridoz  ;Urifos  ;Urinex  ;Urofast  ;Uromaste  ;Uroseptic,Antibiotics,EMEA/H/A-31/1476,,,Nationally authorised product(s),,,,,26/03/2020,09/06/2020,14/12/2018,06/07/2020,https://www.ema.europa.eu/en/medicines/human/referrals/fosfomycin-containing-medicinal-products
Human,Methocarbamol / paracetamol-containing medicinal products,methocarbamol;paracetamol,European Commission final decision,Yes,Article 31 referrals,,Robaxisal compuesto,Analgesic,EMEA/H/A-31/1484,CHMP-EC,,Nationally authorised product(s),,,,,26/03/2020,09/06/2020,29/05/2019,17/06/2020,https://www.ema.europa.eu/en/medicines/human/referrals/methocarbamol-paracetamol-containing-medicinal-products
Human,Cyproterone-containing medicinal products,cyproterone,CMDh final position,Yes,Article 31 referrals,,,antiandrogens,EMEA/H/A-31/1488,,PRAC-CMDh,Nationally authorised product(s),Variation,11/07/2019,13/02/2020,25/03/2020,,,12/07/2019,20/05/2020,https://www.ema.europa.eu/en/medicines/human/referrals/cyproterone-containing-medicinal-products
Veterinary,Veterinary medicinal products containing tylosin base (as a single active substance) presented as solutions for injection for intramuscular use in pigs,tylosin,European Commission final decision,No,,,,,EMA/V/A/131,,,,,,,,05/12/2019,17/04/2020,13/05/2020,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/veterinary-medicinal-products-containing-tylosin-base-single-active-substance-presented-solutions-injection-intramuscular-use-pigs
Veterinary,Ketabel 100 mg/ml solution for injection and associated names,ketamine,European Commission final decision,No,,,,,EMEA/V/A/133,,,Nationally authorised product(s),,,,,05/12/2019,04/03/2020,16/04/2020,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/ketabel-100-mg-ml-solution-injection-and-associated-names
Human,Estradiol-containing (0.01% w/w) medicinal products for topical use,estradiol,CMDh final position,Yes,Article 31 referrals,,Linoladiol  ;Linoladiol N  ;Linoladiol Estradiol  ;Estradiol Wolff  ;Montadiol,Hormonal,EMEA/H/A-31/1482,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,11/04/2019,16/01/2020,30/01/2020,,,12/07/2019,08/04/2020,https://www.ema.europa.eu/en/medicines/human/referrals/estradiol-containing-001-w-w-medicinal-products-topical-use
Human,Xeljanz,tofacitinib,European Commission final decision,Yes,Article 20 procedures,Xeljanz,,,EMEA/H/A-20/1485,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,16/05/2019,31/10/2019,,14/11/2019,31/01/2020,17/05/2019,06/03/2020,https://www.ema.europa.eu/en/medicines/human/referrals/xeljanz
Human,Lemtrada,alemtuzumab,European Commission final decision,Yes,Article 20 procedures,Lemtrada,,,EMEA/H/A-20/1483/C/3718/0028,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,11/04/2019,31/10/2019,,14/11/2019,16/01/2020,12/04/2019,04/02/2020,https://www.ema.europa.eu/en/medicines/human/referrals/lemtrada
Human,Flurbiprofen Geiser,flurbiprofen,European Commission final decision,No,Article 29(4) referrals,,Flurbiprofen Sejmet  ;Mentocaína Spray  ;Flurbiprofeno Geiser,,EMEA/H/A-29(4)/1487,,,Nationally authorised product(s),,,,,17/10/2019,16/12/2019,18/10/2019,20/01/2020,https://www.ema.europa.eu/en/medicines/human/referrals/flurbiprofen-geiser
Veterinary,Veterinary medicinal products containing paromomycin to be administered parenterally to pigs,paromycin,European Commission final decision,No,,,,,EMEA/V/A/129,,,Nationally authorised product(s),,,,,18/07/2019,11/10/2019,20/11/2019,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/veterinary-medicinal-products-containing-paromomycin-be-administered-parenterally-pigs
Veterinary,Veterinary medicinal products containing tylosin presented as solution for injection to be administered to sheep,tylosin,European Commission final decision,No,,,,,EMEA/V/A/130,,,Centrally authorised product(s),,,,,20/06/2019,20/09/2019,19/11/2019,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/veterinary-medicinal-products-containing-tylosin-presented-solution-injection-be-administered-sheep
Human,Methotrexate containing medicinal products,methotrexate,European Commission final decision,Yes,Article 31 referrals,Nordimet;Jylamvo,Jylamvo  ;Nordimet  ;Ledertrexate  ;Maxtrex  ;Metex  ;Metoject,,EMEA/H/A-31/1463,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),Risk minimisation measures,12/04/2018,11/07/2019,,22/08/2019,21/10/2019,13/04/2018,31/10/2019,https://www.ema.europa.eu/en/medicines/human/referrals/methotrexate-containing-medicinal-products
Human,Bacterial lysates-containing medicinal products indicated for respiratory conditions,,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1465,,,Nationally authorised product(s),,,,,27/06/2019,09/09/2019,29/06/2018,16/09/2019,https://www.ema.europa.eu/en/medicines/human/referrals/bacterial-lysates-containing-medicinal-products-indicated-respiratory-conditions
Human,Lartruvo,olaratumab,European Commission final decision,Yes,Article 20 procedures,Lartruvo,,,EMEA/H/A-20/1479/C/4216/015,,,Centrally authorised product(s),,,,,31/01/2019,19/07/2019,01/02/2019,22/08/2019,https://www.ema.europa.eu/en/medicines/human/referrals/lartruvo
Human,Basiron AC and associated names,benzoyl peroxide,European Commission final decision,No,Article 13 referrals,,,,EMA/H/A-13/1475,,,Nationally authorised product(s),,,,,28/03/2019,04/07/2019,29/03/2019,19/07/2019,https://www.ema.europa.eu/en/medicines/human/referrals/basiron-ac-associated-names
Veterinary,Closantel,closantel,European Commission final decision,No,,,,,EMEA/V/A/126,,,,,,,,21/02/2019,20/05/2019,27/06/2019,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/closantel
Human,Fenspiride containing medicinal products,fenspiride,CMDh final position,Yes,Article 107i procedures,,,Drugs for obstructive airway diseases,EMEA/H/A-107i/1480,,PRAC-CMDh,Nationally authorised product(s),,14/02/2019,17/05/2019,29/05/2019,,,15/02/2019,26/06/2019,https://www.ema.europa.eu/en/medicines/human/referrals/fenspiride-containing-medicinal-products
Human,Septanest and associated names,articaine (hydrochloride);adrenaline (tartrate),European Commission final decision,No,Article 30 referrals,,,local anaesthetic,EMEA/H/A-30/1461,,,Nationally authorised product(s),,,,,28/06/2018,28/03/2019,29/06/2018,19/06/2019,https://www.ema.europa.eu/en/medicines/human/referrals/septanest-associated-names
Human,Omega-3 acid ethyl esters - containing medicinal products for oral in use in secondary prevention after myocardial infarction,Omega-3 fatty acid ethyl esters,European Commission final decision,Yes,Article 31 referrals,,,,EMEA/H/A-31/1464,,,Nationally authorised product(s),,,,,13/12/2018,06/06/2019,23/03/2018,13/06/2019,https://www.ema.europa.eu/en/medicines/human/referrals/omega-3-acid-ethyl-esters-containing-medicinal-products-oral-use-secondary-prevention-after-myocardial-infarction
Human,Syner-Kinase and associated names,urokinase,European Commission final decision,No,Article 29(4) referrals,,,,EMA-H-A-29(4)-1472,,,Nationally authorised product(s),,,,,28/02/2019,16/05/2019,01/03/2019,03/06/2019,https://www.ema.europa.eu/en/medicines/human/referrals/syner-kinase-associated-names
Human,Metamizole containing medicinal products,metamizole,European Commission final decision,Yes,Article 31 referrals,,,,EMEA/H/A-31/1469,,,Nationally authorised product(s),,,,,13/12/2018,20/03/2019,01/06/2018,28/03/2019,https://www.ema.europa.eu/en/medicines/human/referrals/metamizole-containing-medicinal-products
Veterinary,Fortekor,benazepril hydrochloride,European Commission final decision,No,,,,,EMEA/V/A/055,,,,,,,,10/11/2011,06/02/2012,24/02/2012,11/03/2019,https://www.ema.europa.eu/en/medicines/veterinary/referrals/fortekor
Human,Diotop capsules,diclofenac;omeprazole,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29(4)/1474,,,Nationally authorised product(s),,,,,15/11/2018,31/01/2019,16/11/2018,15/02/2019,https://www.ema.europa.eu/en/medicines/human/referrals/diotop-capsules
Human,Diclofenac Sodium Spray Gel 4%,diclofenac sodium,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29(4)/1467,,,Nationally authorised product(s),,,,,15/11/2018,18/01/2019,29/01/2019,14/02/2019,https://www.ema.europa.eu/en/medicines/human/referrals/diclofenac-sodium-spray-gel-4
Human,Perlinring and associated names,etonogestrel;ethinylestradiol,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29(4)/1473,,,Nationally authorised product(s),,,,,18/10/2018,18/12/2018,19/10/2018,21/01/2019,https://www.ema.europa.eu/en/medicines/human/referrals/perlinring-and-associated-names
Human,Paclitaxel Hetero and associated names,paclitaxel,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29(4)/1466,,,Nationally authorised product(s),,,,,18/10/2018,11/01/2019,19/10/2018,21/01/2019,https://www.ema.europa.eu/en/medicines/human/referrals/paclitaxel-hetero-associated-names
Human,Xofigo,radium Ra223 dichloride,European Commission final decision,No,Article 20 procedures,Xofigo,,,EMEA/H/A-20/1459/C/002653/0028,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,30/11/2017,12/07/2018,,26/07/2018,28/09/2018,01/12/2017,11/10/2018,https://www.ema.europa.eu/en/medicines/human/referrals/xofigo
Human,Esmya,ulipristal acetate,European Commission final decision,No,Article 20 procedures,Esmya,,,EMEA/H/A-20/1460/C/2041/0043,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,30/11/2017,17/05/2018,,31/05/2018,26/07/2018,01/12/2017,08/08/2018,https://www.ema.europa.eu/en/medicines/human/referrals/esmya
Human,Scandonest and associated names,mepivacaine,European Commission final decision,No,Article 30 referrals,,Biocaine  ;Scandicaine,Anaesthetic,EMEA/H/A-30/1455,,,,,,,,31/05/2018,02/08/2018,15/09/2017,07/08/2018,https://www.ema.europa.eu/en/medicines/human/referrals/scandonest-associated-names
Human,Zinbryta,,European Commission final decision,No,Article 20 procedures,Zinbryta,,,EMEA/H/A-20/1462/C/003862/0018,,PRAC-CHMP-EC,Centrally authorised product(s),Suspension,02/03/2018,17/05/2018,,,27/03/2018,02/03/2018,11/07/2018,https://www.ema.europa.eu/en/medicines/human/referrals/zinbryta
Veterinary,Seresto and its associated name Foresto,imidacloprid;flumethrin,European Commission final decision,No,,,,,EMEA/V/A/125,,,,,,,,15/02/2018,25/05/2018,10/07/2018,10/07/2018,https://www.ema.europa.eu/en/medicines/veterinary/referrals/seresto-its-associated-name-foresto
Human,Maci,matrix applied characterised autologous cultured chondrocytes,European Commission final decision,No,Article 20 procedures,Maci,,Advanced therapies,EMEA/H/A20/1409/C/002522/0004,CAT-CHMP-EC,,,,,,,25/09/2014,19/11/2014,26/09/2014,05/07/2018,https://www.ema.europa.eu/en/medicines/human/referrals/maci
Human,Retinoid-containing medicinal products,acitretin;adapalene;alitretinoin;bexarotene;isotretinoin;tretinoin;tazarotene,European Commission final decision,No,Article 31 referrals,Targretin;Panretin,,dermatological agents,EMEA/H/A-31/1446,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),Risk minimisation measures,07/07/2016,08/02/2018,,22/03/2018,21/06/2018,08/07/2016,02/07/2018,https://www.ema.europa.eu/en/medicines/human/referrals/retinoid-containing-medicinal-products
Veterinary,Girolan and its associated name Apralan,apramycin sulfate,European Commission final decision,No,,,,,EMEA-V-A-122,,,,,,,,,,15/06/2018,15/06/2018,https://www.ema.europa.eu/en/medicines/veterinary/referrals/girolan-its-associated-name-apralan
Human,Valproate and related substances,sodium valproate;valproate magnesium;valproate semisodium;valproic acid;valpromide,European Commission final decision,No,Article 31 referrals,,Absenor  ;Convival Chrono  ;Convulex  ;Delepsine  ;Depakin  ;Depakine  ;Depakote  ;Depamag  ;Depamide  ;Deprakine  ;Diplexil  ;Dipromal  ;Epilim  ;Episenta  ;Epival  ;Ergenyl  ;Espa-Valept  ;Hexaquin  ;Kentlim  ;Leptilan  ;Micropakine L.P.  ;Orfiril  ;Petilin  ;Valepil  ;Valhel PR  ;Valpal  ;Valpro and Valprolek,,EMEA/H/A-31/1454,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,09/03/2017,08/02/2018,21/03/2018,,31/05/2018,10/03/2017,07/06/2018,https://www.ema.europa.eu/en/medicines/human/referrals/valproate-related-substances-0
Human,Flupirtine-containing medicinal products,flupirtine,CMDh final position,No,Article 31 referrals,,,Analgesics,EMEA/H/A-31/1458,,PRAC-CMDh,Nationally authorised product(s),Revocation,26/10/2017,08/02/2018,21/03/2018,,,27/10/2017,04/05/2018,https://www.ema.europa.eu/en/medicines/human/referrals/flupirtine-containing-medicinal-products
Human,Paracetamol modified-release,paracetamol,European Commission final decision,Yes,Article 31 referrals,,Alvedon,analgesics/antipyretics,EMEA/H/A-31/1445,,PRAC-CMDh,Nationally authorised product(s),Suspension,07/07/2016,01/09/2017,13/12/2017,,19/02/2018,08/07/2016,01/03/2018,https://www.ema.europa.eu/en/medicines/human/referrals/paracetamol-modified-release
Human,Hydroxyethyl starch solutions for infusion,hydroxyethyl starch,European Commission final decision,No,Article 31 referrals,,,-,EMEA/H/A-31/1348,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,29/11/2012,10/10/2013,,23/10/2013,19/12/2013,30/11/2012,12/01/2018,https://www.ema.europa.eu/en/medicines/human/referrals/hydroxyethyl-starch-solutions-infusion
Human,Alcover and associated names,sodium oxybate,European Commission final decision,No,Article 29(4) referrals,,n/a,-,EMEA/H/A-29(4)/1451,,,,,,,,26/01/2017,18/12/2017,23/06/2017,12/01/2018,https://www.ema.europa.eu/en/medicines/human/referrals/alcover-associated-names
Human,Zinbryta,daclizumab,European Commission final decision,No,Article 20 procedures,Zinbryta,,-,EMEA/H/A-20/1456/C/003862/0010,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,09/06/2017,26/10/2017,,09/11/2017,08/01/2018,09/06/2017,12/01/2018,https://www.ema.europa.eu/en/medicines/human/referrals/zinbryta-0
Human,Factor VIII,,European Commission final decision,No,Article 31 referrals,Iblias;Elocta;Kovaltry;Nuwiq;Obizur;NovoEight;Voncento;ReFacto AF;Kogenate Bayer;Helixate NexGen;Advate,,-,EMEA/H/A-31/1448,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),Risk minimisation measures,07/07/2016,01/09/2017,,14/09/2017,10/10/2017,08/07/2016,05/12/2017,https://www.ema.europa.eu/en/medicines/human/referrals/factor-viii
Human,Gadolinium-containing contrast agents,gadobenic acid;gadobutrol;gadodiamide;gadopentetic acid;gadoteric acid;gadoteridol;gadoversetamide;gadoxetic acid,European Commission final decision,No,Article 31 referrals,Optimark,,-,EMEA/H/A-31/1437,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),Suspension,17/03/2016,06/07/2017,,20/07/2017,23/11/2017,18/03/2016,04/12/2017,https://www.ema.europa.eu/en/medicines/human/referrals/gadolinium-containing-contrast-agents
Human,Vancomycin-containing medicines,vancomycin,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1440,,,,,,,,18/05/2017,21/09/2017,01/04/2016,17/11/2017,https://www.ema.europa.eu/en/medicines/human/referrals/vancomycin-containing-medicines
Veterinary,Lincocin and its associated names,lincomycin,European Commission final decision,No,,,,,EMEA/V/A/123,,,,,,,,13/07/2017,05/10/2017,14/11/2017,14/11/2017,https://www.ema.europa.eu/en/medicines/veterinary/referrals/lincocin-its-associated-names
Veterinary,"Zanil and associated names, and generic products thereof",oxyclozanide,European Commission final decision,No,,,,,EMEA/V/A/124,,,,,,,,13/07/2017,28/09/2017,25/10/2017,25/10/2017,https://www.ema.europa.eu/en/medicines/veterinary/referrals/zanil-associated-names-generic-products-thereof
Veterinary,"Moxidectin-containing veterinary medicines used in cattle, sheep and horses",moxidectin,European Commission final decision,No,,,,,EMEA/V/A/116,,,,,,,,11/05/2017,,24/10/2017,24/10/2017,https://www.ema.europa.eu/en/medicines/veterinary/referrals/moxidectin-containing-veterinary-medicines-used-cattle-sheep-horses
Human,Symbioflor 2,escherichia coli bacteria (cells and autolysate),European Commission final decision,No,Article 31 referrals,,Symbioflor E. Coli  ;Symbioflor® 2  ;Symbioflor Escherichia,"Other immunostimulants, Antidiarrheal microorganisms",EMEA/H/A-31/1441,,,,,,,,,22/06/2017,01/04/2016,07/09/2017,https://www.ema.europa.eu/en/medicines/human/referrals/symbioflor-2
Human,Medicinal products containing lactose of bovine origin for IV/IM use in acute allergic reactions,methylprednisolone,CMDh final position,No,Article 31 referrals,,,,EMEA/H/A-31/1449,,PRAC-CMDh,Nationally authorised product(s),Variation,01/12/2016,06/07/2017,31/07/2017,,,02/12/2016,04/09/2017,https://www.ema.europa.eu/en/medicines/human/referrals/medicinal-products-containing-lactose-bovine-origin-iv-im-use-acute-allergic-reactions
Human,Paracetamol/Ibuprofen 500 mg/150 mg film-coated tablets,paracetamol;ibuprofen,European Commission final decision,No,Article 29(4) referrals,,Paracomb,,EMEA/H/A-29(4)/1447,,,,,,,,18/05/2017,07/08/2017,19/05/2017,18/08/2017,https://www.ema.europa.eu/en/medicines/human/referrals/paracetamol-ibuprofen-500-mg-150-mg-film-coated-tablets
Veterinary,Zinc oxide,zinc oxide,European Commission final decision,No,,,,,EMEA/V/A/118,,,,,,,,16/03/2017,26/06/2017,14/08/2017,14/08/2017,https://www.ema.europa.eu/en/medicines/veterinary/referrals/zinc-oxide
Veterinary,Denagard 45%,tiamulin hydrogen fumarate,European Commission final decision,No,,,,,EMEA/V/A/114,,,,,,,,12/04/2017,14/07/2017,11/08/2017,11/08/2017,https://www.ema.europa.eu/en/medicines/veterinary/referrals/denagard-45
Veterinary,Methylprednisolone injection for cattle,methylprednisolone hydrogen succinate,European Commission final decision,No,,,,,EMEA/V/A/119,,,,,,,,16/03/2017,20/06/2017,04/08/2017,04/08/2017,https://www.ema.europa.eu/en/medicines/veterinary/referrals/methylprednisolone-injection-cattle
Veterinary,Tylosin injection for mastitis,tylosin,European Commission final decision,No,,,,,EMEA-V-A-121,,,,,,,,16/03/2017,10/07/2017,31/07/2017,31/07/2017,https://www.ema.europa.eu/en/medicines/veterinary/referrals/tylosin-injection-mastitis
Human,Cardioxane,dexrazoxane,European Commission final decision,No,Article 13 referrals,,,,EMEA/H/A-13/1453,,,,,,,,19/07/2017,19/07/2017,19/05/2017,26/07/2017,https://www.ema.europa.eu/en/medicines/human/referrals/cardioxane
Human,Vepesid,etoposide,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1425,,,,,,,,21/04/2017,26/06/2017,21/04/2017,14/07/2017,https://www.ema.europa.eu/en/medicines/human/referrals/vepesid
Human,Etopophos,etoposide phosphate,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1417,,,,,,,,21/04/2017,26/06/2017,21/04/2017,14/07/2017,https://www.ema.europa.eu/en/medicines/human/referrals/etopophos
Human,Micro Therapeutic Research,,European Commission final decision,No,Article 31 referrals,,,-,EMEA/H/A-31/1450,,,,,,,,23/03/2017,23/06/2017,16/12/2016,10/07/2017,https://www.ema.europa.eu/en/medicines/human/referrals/micro-therapeutic-research
Human,Saroten and associated names,amitriptyline,European Commission final decision,No,Article 30 referrals,,Saroten Retard  ;Redomex  ;Redomex Diffucaps  ;Saroten Tabs  ;Saroten retard Tabs  ;Saroten 2ml  ;Sarotex  ;Sarotex Retard  ;Sarotex Retard 25  ;Sarotex Retard 50,antidepressant,EMEA/H/A-30/1430,,,,,,,,23/02/2017,08/05/2017,24/02/2017,06/06/2017,https://www.ema.europa.eu/en/medicines/human/referrals/saroten-associated-names
Human,Haldol Decanoate and associated names,haloperidol decanoate,European Commission final decision,No,Article 30 referrals,,Haldol Decanoat  ;Haldol Decanoas  ;Serenase Dekanoat  ;Serenase Depot  ;Haldol - Janssen Decanoat Depot  ;Haldol Decanoato  ;Haldol Depot,,EMEA/H/A-30/1405,,,,,,,,23/02/2017,28/04/2017,24/02/2017,11/05/2017,https://www.ema.europa.eu/en/medicines/human/referrals/haldol-decanoate-associated-names
Human,SGLT2 inhibitors (previously canagliflozin),canagliflozin;empagliflozin;dapagliflozin;metformin,European Commission final decision,No,Article 20 procedures,Xigduo;Ebymect;Edistride;Synjardy;Forxiga;Jardiance;Vokanamet;Invokana,,,EMEA/H/A-20/1442,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,15/04/2016,09/02/2017,,23/02/2017,04/05/2017,15/04/2016,08/05/2017,https://www.ema.europa.eu/en/medicines/human/referrals/sglt2-inhibitors-previously-canagliflozin
Human,Haldol and associated names,haloperidol,European Commission final decision,No,Article 30 referrals,,Aloperidin  ;Haldol-Janssen  ;Serenase,,EMEA/H/A-30/1393,,,,,,,,23/02/2017,28/04/2017,24/02/2017,05/05/2017,https://www.ema.europa.eu/en/medicines/human/referrals/haldol-associated-names
Veterinary,Veterinary medicinal products containing gentamicin presented as solutions for injection to be administered to cattle and pigs,gentamicin,European Commission final decision,No,,,,,EMEA/V/A/117,,,,,,,,10/11/2016,27/02/2017,21/04/2017,21/04/2017,https://www.ema.europa.eu/en/medicines/veterinary/referrals/veterinary-medicinal-products-containing-gentamicin-presented-solutions-injection-be-administered-cattle-pigs
Human,Dienogest/ethinylestradiol-containing medicinal products indicated in acne,dienogest;ethinyl estradiol,European Commission final decision,Yes,Article 31 referrals,,,-,EMEA/H/A-31/1435,,,,,,,,26/01/2017,22/03/2017,26/02/2016,24/03/2017,https://www.ema.europa.eu/en/medicines/human/referrals/dienogest-ethinylestradiol-containing-medicinal-products-indicated-acne
Human,Lovenox and associated names,enoxaparin,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1429,,,,,,,,15/12/2016,09/03/2017,16/12/2016,22/03/2017,https://www.ema.europa.eu/en/medicines/human/referrals/lovenox-associated-names
Human,Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free),daclatasvir;dasabuvir;sofosbuvir;ledipasvir;simeprevir;ombitasvir;paritaprevir;ritonavir,European Commission final decision,No,Article 20 procedures,Sovaldi;Olysio;Viekirax;Harvoni;Exviera;Daklinza,,,EMEA/H/A-20/1438,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,17/03/2016,01/12/2016,,15/12/2016,23/02/2017,18/03/2016,09/03/2017,https://www.ema.europa.eu/en/medicines/human/referrals/direct-acting-antivirals-indicated-treatment-hepatitis-c-interferon-free
Human,Metformin and metformin-containing medicines,metformin,European Commission final decision,No,Article 31 referrals,Xigduo;Vipdomet;Velmetia;Synjardy;Ristfor;Komboglyze;Jentadueto;Janumet;Icandra (previously Vildagliptin / metformin hydrochloride Novartis);Glubrava;Eucreas;Efficib;Ebymect;Competact,,,EMEA/H/A-31/1432,,,,,,,,13/10/2016,12/12/2016,29/01/2016,21/12/2016,https://www.ema.europa.eu/en/medicines/human/referrals/metformin-metformin-containing-medicines
Human,Pharmaceutics International Inc.,sodium phenylbutyrate;progesterone;dutasteride;colecalciferol,European Commission final decision,No,Article 31 referrals,Ammonaps,,,EMEA/H/A-31/1444,,,,,,,,15/09/2016,05/12/2016,24/06/2016,14/12/2016,https://www.ema.europa.eu/en/medicines/human/referrals/pharmaceutics-international-inc
Human,Clenil and associated names,beclometasone dipropionate,European Commission final decision,No,Article 30 referrals,,Becloneb  ;Beclospin and Sanasthmax,,EMEA/H/A-30/1418,,,,,,,,15/09/2016,11/11/2016,16/09/2016,18/11/2016,https://www.ema.europa.eu/en/medicines/human/referrals/clenil-associated-names
Human,Semler,,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1443,,,,,,,,21/07/2016,22/09/2016,29/04/2016,17/11/2016,https://www.ema.europa.eu/en/medicines/human/referrals/semler
Human,Durogesic and associated names,fentanyl,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1413,,,,,,,,21/07/2016,22/09/2016,22/07/2016,19/10/2016,https://www.ema.europa.eu/en/medicines/human/referrals/durogesic-associated-names
Human,Diclofenac epolamine 50 mg tablets,diclofenac,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1434,,,,,,,,25/02/2016,22/09/2016,22/07/2016,10/10/2016,https://www.ema.europa.eu/en/medicines/human/referrals/diclofenac-epolamine-50-mg-tablets
Human,Alkem,,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1436,,,,,,,,23/06/2016,08/09/2016,01/04/2016,07/10/2016,https://www.ema.europa.eu/en/medicines/human/referrals/alkem
Human,Zydelig,idelalisib,European Commission final decision,No,Article 20 procedures,Zydelig,,,EMEA/H/A-20/1439/C/3843/0023,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,17/03/2016,07/07/2016,,21/07/2016,15/09/2016,18/03/2016,03/10/2016,https://www.ema.europa.eu/en/medicines/human/referrals/zydelig
Veterinary,"Veterinary medicinal products containing a combination of lincomycin and spectinomycin to be administered orally to pigs and, or poultry",lincomycin;spectinomycin,European Commission final decision,No,,,,,EMEA/V/A/110,,,,,,,,19/05/2016,22/08/2016,16/09/2016,16/09/2016,https://www.ema.europa.eu/en/medicines/veterinary/referrals/veterinary-medicinal-products-containing-combination-lincomycin-spectinomycin-be-administered-orally-pigs-or-poultry
Veterinary,Altrenogest,altrenogest,European Commission final decision,No,,,,-,EMEA/V/A/095,,,,,,,,19/05/2016,29/07/2016,08/09/2016,08/09/2016,https://www.ema.europa.eu/en/medicines/veterinary/referrals/altrenogest
Human,Levonelle 1500 microgram tablets and associated names,levonorgestrel,European Commission final decision,No,Article 13 referrals,,,,EMEA/H/A-13/1427,,,,,,,,26/05/2016,01/08/2016,27/05/2016,09/08/2016,https://www.ema.europa.eu/en/medicines/human/referrals/levonelle-1500-microgram-tablets-associated-names
Veterinary,Colistin combinations,Colistin sulfate;oxytetracycline hydrochloride;trimethoprim;enrofloxacin;Amoxicillin trihydrate;spiramycin adipate;ampicillin trihydrate;erythromycin estolate;scopolamine;sulfaguanidine;neomycin sulfate;sulfadimethoxine;sulfamethoxypyridazine;doxycycline hyclate;sulfadimidine sodium;chlortetracycline hydrochloride,European Commission final decision,No,,,,,EMEA/V/A/111,,,,,,,,21/04/2016,14/07/2016,05/08/2016,05/08/2016,https://www.ema.europa.eu/en/medicines/veterinary/referrals/colistin-combinations
Veterinary,Benzathine benzylpenicillin intended for administration to food-producing species,benzathine benzylpenicillin,European Commission final decision,No,,,,,EMEA/V/A/20/002,,,,,,,,15/01/2003,22/04/2003,13/08/2014,26/07/2016,https://www.ema.europa.eu/en/medicines/veterinary/referrals/benzathine-benzylpenicillin-intended-administration-food-producing-species
Veterinary,CattleMarker IBR Inactivated,Infectious bovine rhinotracheitis vaccine (inactivated),European Commission final decision,No,,,,,EMEA/V/A/115,,,,,,,,17/03/2016,10/06/2016,19/07/2016,19/07/2016,https://www.ema.europa.eu/en/medicines/veterinary/referrals/cattlemarker-ibr-inactivated
Human,Inhaled corticosteroids containing medicinal products indicated in the treatment of chronic obstructive pulmonary disease,beclometasone;budesonide;flunisolide;fluticasone propionate;fluticasone furoate,European Commission final decision,No,Article 31 referrals,,,-,EMEA/H/A-31/1415,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),Variation,07/05/2015,17/03/2016,,28/04/2016,29/06/2016,08/05/2015,15/07/2016,https://www.ema.europa.eu/en/medicines/human/referrals/inhaled-corticosteroids-containing-medicinal-products-indicated-treatment-chronic-obstructive-pulmonary-disease
Human,Novantrone and associated names,mitoxantrone,European Commission final decision,No,Article 30 referrals,,Elsep  ;Ralenova,Antineoplastic agent,EMEA/H/A-30/1399,,,,,,,,28/04/2016,24/06/2016,29/04/2016,05/07/2016,https://www.ema.europa.eu/en/medicines/human/referrals/novantrone-associated-names
Human,Cymevene,ganciclovir,European Commission final decision,No,Article 30 referrals,,Cymevan  ;Citovirax,Antiviral,EMEA/H/A-30/1406,,,,,,,,25/02/2016,28/04/2016,26/02/2016,21/06/2016,https://www.ema.europa.eu/en/medicines/human/referrals/cymevene
Veterinary,Closamectin Pour-on Solution and associated names,ivermectin;closantel,European Commission final decision,No,,,,,EMEA/V/A/113,,,,,,,,08/10/2015,22/03/2016,31/05/2016,31/05/2016,https://www.ema.europa.eu/en/medicines/veterinary/referrals/closamectin-pour-solution-associated-names
Human,Amoxil,amoxicillin,European Commission final decision,No,Article 30 referrals,,,-,EMEA/H/A-30/1372,,,,,,,,25/06/2015,20/08/2015,26/06/2015,19/05/2016,https://www.ema.europa.eu/en/medicines/human/referrals/amoxil
Human,SGLT2 inhibitors,canagliflozin;dapagliflozin;empagliflozin,European Commission final decision,No,Article 20 procedures,Edistride;Ebymect;Xigduo;Vokanamet;Synjardy;Jardiance;Invokana;Forxiga,,,EMEA/H/A-20/1419,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,11/06/2015,11/02/2016,,25/02/2016,28/04/2016,12/06/2015,18/05/2016,https://www.ema.europa.eu/en/medicines/human/referrals/sglt2-inhibitors
Human,Tysabri,natalizumab,European Commission final decision,No,Article 20 procedures,Tysabri,,-,EMEA/H/A-20/1416/C/000603/0083,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,07/05/2015,11/02/2016,,25/02/2016,25/04/2016,08/05/2015,12/05/2016,https://www.ema.europa.eu/en/medicines/human/referrals/tysabri
Human,Tobramycin VVB and associated names,tobramycin,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1428,,,,,,,,28/01/2015,04/04/2016,29/01/2016,04/05/2016,https://www.ema.europa.eu/en/medicines/human/referrals/tobramycin-vvb-associated-names
Human,Fusafungine containing medicinal products for oromucosal and nasal use,fusafungine,CMDh final position,No,Article 31 referrals,,,-,EMEA/H/A-31/1420,,PRAC-CMDh,Nationally authorised product(s),Revocation,10/09/2015,11/02/2016,,31/03/2016,,11/09/2015,14/04/2016,https://www.ema.europa.eu/en/medicines/human/referrals/fusafungine-containing-medicinal-products-oromucosal-nasal-use
Human,Ambroxol and bromhexine-containing medicines,ambroxol;bromhexine,European Commission final decision,No,Article 31 referrals,,,-,EMEA/H/A-31/1397,,PRAC-CMDh,Nationally authorised product(s),Variation,10/04/2014,10/09/2015,18/11/2015,,14/01/2016,11/04/2014,05/02/2016,https://www.ema.europa.eu/en/medicines/human/referrals/ambroxol-bromhexine-containing-medicines
Veterinary,"Solamocta 697 mg/g powder for use in drinking water for chickens, ducks and turkeys",Amoxicillin trihydrate,European Commission final decision,No,,,,-,EMEA/V/A/112,,,,,,,,04/11/2015,07/01/2016,05/02/2016,05/02/2016,https://www.ema.europa.eu/en/medicines/veterinary/referrals/solamocta-697-mg-g-powder-use-drinking-water-chickens-ducks-turkeys
Human,"Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard","bivalent HPV vaccine (types 16, 18);quadrivalent HPV vaccine (types 6, 11, 16, 18);9-valent HPV vaccine (types 6, 11, 16, 18, 31, 33, 45, 52 and 58)",European Commission final decision,No,Article 20 procedures,,Cervarix  ;Gardasil  ;Gardasil 9  ;Silgard,,EMEA/H/A-20/1421,,PRAC-CHMP-EC,Centrally authorised product(s),No further action,09/07/2015,06/11/2015,,19/11/2015,12/01/2016,13/07/2015,20/01/2016,https://www.ema.europa.eu/en/medicines/human/referrals/human-papillomavirus-vaccines-cervarix-gardasil-gardasil-9-silgard
Human,Inductos,dibotermin alfa,European Commission final decision,No,Article 20 procedures,Inductos,,,EMEA/H/A-20/1422/C/0408/0082,,,,,,,,22/10/2015,20/11/2015,24/07/2015,07/12/2015,https://www.ema.europa.eu/en/medicines/human/referrals/inductos
Veterinary,Gutal,zinc oxide,European Commission final decision,No,,,,-,EMEA/V/A/108,,,,,,,,06/05/2015,22/10/2015,26/11/2015,26/11/2015,https://www.ema.europa.eu/en/medicines/veterinary/referrals/gutal
Veterinary,Coglapix suspension for injection for pigs,inactivated porcine actinobacillosis vaccine,European Commission final decision,No,,,,,EMEA/V/A/109,,,,,,,,03/06/2015,28/08/2015,02/10/2015,02/10/2015,https://www.ema.europa.eu/en/medicines/veterinary/referrals/coglapix-suspension-injection-pigs
Human,Adrenaline auto-injectors,adrenaline (epinephrine),European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1398,,,,,,,,25/06/2015,14/08/2015,25/04/2014,26/08/2015,https://www.ema.europa.eu/en/medicines/human/referrals/adrenaline-auto-injectors
Human,GVK Biosciences,esomeprazole magnesium;candesartan cilexetil;nebivolol;desloratadine;donepezil;repaglinide;candesartan;esomeprazole;alendronic acid;ropinirole;cefpodoxime;quetiapine;trimetazidine;bosentan;tramadol;paracetamol;escitalopram;trimetazidine hydrochloride;entacapone;valsartan;hydrochlorothiazide;donepezil hydrochloride;ropinirole hydrochloride;clopidogrel hydrochloride;escitalopram oxalate;metformin hydrochloride;trimetazidine dihydrochloride;rizatriptan benzoate;metformin;fluconazole;eletriptan;rizatriptan;ebastine;ibuprofen;desmopressin;aciclovir;levetiracetam;irbesartan;venlafaxine;ciprofloxacin;cefpodoxime proxetil;tacrolimus;fexofenadine hydrochloride;phenoxymethylpenicillin;amlodipine besilate;metoclopramide;clopidogrel;levodopa;carbidopa;entacapone;atorvastatin;telmisartan;clindamycin hydrochloride;metoclopramide hydrochloride;clonazepam;clobazam;dexamethasone;thiamine hydrochloride;tramadol hydrochloride;pioglitazone;dipyridamole;fexofenadine;amlodipine;pantoprazole;hydrocortisone,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1408,,,,,,,,21/05/2015,16/07/2015,26/09/2014,04/08/2015,https://www.ema.europa.eu/en/medicines/human/referrals/gvk-biosciences
Human,Myoson and associated names,tolperisone,European Commission final decision,No,Article 29(4) referrals,,,-,EMEA/H/A-29/1411 EMEA/H/A-29/1412,,,,,,,,23/04/2015,,28/07/2015,28/07/2015,https://www.ema.europa.eu/en/medicines/human/referrals/myoson-associated-names
Human,Merisone and associated names,tolperisone,European Commission final decision,No,Article 29(4) referrals,,,-,EMEA/H/A-29/1411,,,,,,,,23/04/2015,25/06/2015,24/04/2015,28/07/2015,https://www.ema.europa.eu/en/medicines/human/referrals/merisone-associated-names
Human,Ibuprofen- and dexibuprofen-containing medicines,ibuprofen;dexibuprofen,CMDh final position,No,Article 31 referrals,,,,EMEA/H/A-31/1401,,PRAC-CMDh,Nationally authorised product(s),Variation,13/06/2014,10/04/2015,20/05/2015,,,13/06/2014,14/07/2015,https://www.ema.europa.eu/en/medicines/human/referrals/ibuprofen-dexibuprofen-containing-medicines
Human,Ikorel and Dancor,nicorandil,European Commission final decision,No,Article 30 referrals,,,cardiovascular,EMEA/H/A-30/1380,,,,,,,,26/03/2015,05/06/2015,27/03/2015,30/06/2015,https://www.ema.europa.eu/en/medicines/human/referrals/ikorel-dancor
Human,Hydroxyzine,hydroxyzine,CMDh final position,No,Article 31 referrals,,Atarax,,EMEA/H/A-31/1400,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,08/05/2014,12/02/2015,25/03/2015,,,08/05/2014,08/06/2015,https://www.ema.europa.eu/en/medicines/human/referrals/hydroxyzine
Human,Codeine-containing medicinal products for the treatment of cough or cold in paediatric patients,,CMDh final position,No,Article 31 referrals,,,,EMEA/H/A-31/1394,,PRAC-CMDh,Nationally authorised product(s),Variation,10/04/2014,12/03/2015,22/04/2015,,,11/04/2014,18/05/2015,https://www.ema.europa.eu/en/medicines/human/referrals/codeine-containing-medicinal-products-treatment-cough-or-cold-paediatric-patients
Veterinary,Colistin oral,colistin,European Commission final decision,No,,,,Polymyxins,EMEA/V/A/106,,,,,,,,11/12/2014,16/03/2015,13/04/2015,13/04/2015,https://www.ema.europa.eu/en/medicines/veterinary/referrals/colistin-oral
Veterinary,Gentamicin,gentamicin,European Commission final decision,No,,,,Aminoglycosides,EMEA/V/A/104,,,,,,,,06/11/2014,11/02/2015,10/04/2015,,https://www.ema.europa.eu/en/medicines/veterinary/referrals/gentamicin
Human,Plendil and associated names,felodipine,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1385,,,,,,,,23/10/2014,16/12/2014,24/10/2014,30/03/2015,https://www.ema.europa.eu/en/medicines/human/referrals/plendil-associated-names
Human,Iclusig,ponatinib,European Commission final decision,No,Article 20 procedures,Iclusig,,,EMEA/H/C/2695/A20/0003,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,05/12/2013,09/10/2014,,23/10/2014,15/01/2015,06/12/2013,02/03/2015,https://www.ema.europa.eu/en/medicines/human/referrals/iclusig
Human,Corlentor and Procoralan,ivabradine,European Commission final decision,No,Article 20 procedures,,Corlentor and Procoralan,,EMEA/H/A20/1404/C/000598/0031 EMEA/H/A20/1404/C/000597/0032,,PRAC-CHMP-EC,Centrally authorised product(s),Risk minimisation measures,08/05/2014,06/11/2014,,20/11/2014,15/01/2015,08/05/2014,16/02/2015,https://www.ema.europa.eu/en/medicines/human/referrals/corlentor-procoralan
Veterinary,Suanovil 20 / Captalin associated names and generic products thereof,spiramycin,European Commission final decision,No,,,,,EMEA/V/A/086,,,,,,,,09/09/2014,11/12/2014,03/02/2015,03/02/2015,https://www.ema.europa.eu/en/medicines/veterinary/referrals/suanovil-20-captalin-associated-names-generic-products-thereof
Human,Nasonex,mometasone furoate,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1374,,,,,,,,20/11/2014,19/01/2015,21/11/2014,03/02/2015,https://www.ema.europa.eu/en/medicines/human/referrals/nasonex
Human,Seasonique and associated names,levonorgestrel;ethinylestradiol,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/139,,,,,,,,20/11/2014,12/01/2015,27/06/2014,29/01/2015,https://www.ema.europa.eu/en/medicines/human/referrals/seasonique-associated-names
Human,Valproate and related substances,sodium valproate;valproic acid;valproate semisodium;valpromide,CMDh final position,No,Article 31 referrals,,Absenor  ;Convival Chrono  ;Convulex  ;Convulsofin Tabletten  ;Delepsine  ;Depakine  ;Deprakine  ;Diplexil  ;Dipromal  ;Epilim  ;Episenta  ;Epival  ;Ergenyl  ;Espa-Valept  ;Hexaquin  ;Leptilan  ;Micropakine L.P.  ;Orfiril  ;Orlept  ;Petilin  ;Valberg  ;Valepil and Valhel,,EMEA/H/A-31/1387,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,10/10/2013,09/10/2014,,19/11/2014,,11/10/2013,29/01/2015,https://www.ema.europa.eu/en/medicines/human/referrals/valproate-related-substances
Human,Oxynal Targin and associated names,oxycodone hydrochloride;naloxone hydrochloride,European Commission final decision,No,Article 13 referrals,,,,EMEA/H/A-13/1402,,,,,,,,23/10/2014,22/12/2014,24/10/2014,27/01/2015,https://www.ema.europa.eu/en/medicines/human/referrals/oxynal-targin-associated-names
Human,EMLA cream and associated names,lidocaine;prilocaine,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1388,,,,,,,,25/09/2014,28/11/2014,26/09/2014,15/01/2015,https://www.ema.europa.eu/en/medicines/human/referrals/emla-cream-associated-names
Veterinary,Resflor solution injectable and associated names,florfenicol;flunixin,European Commission final decision,No,,,,,EMEA/V/A/101,,,,,,,,07/10/2014,05/12/2014,09/01/2015,09/01/2015,https://www.ema.europa.eu/en/medicines/veterinary/referrals/resflor-solution-injectable-associated-names
Human,Testosterone-containing medicines,testosterone,CMDh final position,No,Article 31 referrals,,,,EMEA/H/A-31/1396,,PRAC-CMDh,Nationally authorised product(s),Variation,10/04/2014,09/10/2014,,19/11/2014,,11/04/2014,08/01/2015,https://www.ema.europa.eu/en/medicines/human/referrals/testosterone-containing-medicines
Human,Polymyxin-containing medicines,colistimethate sodium,European Commission final decision,No,Article 31 referrals,Colobreathe,Colobreathe,antibiotics,EMEA/H/A-31/1383,,,,,,,,23/10/2014,16/12/2014,24/10/2014,05/01/2015,https://www.ema.europa.eu/en/medicines/human/referrals/polymyxin-containing-medicines
Veterinary,Baytril injectable and generics,enrofloxacin,European Commission final decision,No,,,,,EMEA/V/A/097,,,,,,,,09/04/2014,01/09/2014,10/12/2014,10/12/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/baytril-injectable-generics
Veterinary,Baytril injectable,enrofloxacin,European Commission final decision,No,,,,,EMEA/V/A/091,,,,,,,,09/04/2014,01/09/2014,10/12/2014,10/12/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/baytril-injectable
Human,Bromocriptine-containing medicines indicated in the prevention or suppression of physiological lactation post-partum,bromocriptine,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1379,,PRAC-CMDh,Nationally authorised product(s),Variation,05/09/2013,10/07/2014,,20/08/2014,30/10/2014,06/09/2013,08/12/2014,https://www.ema.europa.eu/en/medicines/human/referrals/bromocriptine-containing-medicines-indicated-prevention-or-suppression-physiological-lactation-post-partum
Human,Emergency contraceptives,levonorgestrel;ulipristal acetate,European Commission final decision,No,Article 31 referrals,,Norlevo  ;Levonelle/Postinor and Levodonna  ;ellaOne,,EMEA/H/A-31/1391,,,,,,,,24/07/2014,30/09/2014,24/07/2014,24/10/2014,https://www.ema.europa.eu/en/medicines/human/referrals/emergency-contraceptives
Human,Renin-angiotensin-system (RAS)-acting agents,captopril;imidapril;zofenopril;candesartan;delapril;telmisartan;aliskiren;moexipril;enalapril;valsartan;fosinopril;irbesartan;perindopril;quinapril;ramipril;eprosartan;olmesartan;trandolapril;losartan;azilsartan;lisinopril;spirapril;benazepril;cilazapril,European Commission final decision,No,Article 31 referrals,Tolucombi;Telmisartan Teva;Telmisartan Teva Pharma;Tolura;Onduarp;Twynsta;Actelsar HCT;Kinzalkomb;MicardisPlus;PritorPlus;Copalia HCT;Dafiro HCT;Exforge HCT;Rasilamlo;Rasilez;Rasilez HCT;Rasitrio;Edarbi;Ipreziv;Aprovel;Ifirmasta (previously Irbesartan Krka);Irbesartan Teva;Irbesartan Zentiva (previously Irbesartan Winthrop);Karvea;Sabervel;CoAprovel;Ifirmacombi;Irbesartan/Hydrochlorothiazide Teva;Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop);Karvezide;Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG);Micardis;Pritor;Telmisartan Actavis,,"angiotensin-receptor blockers (ARBs), angiotensin-converting-enzyme inhibitors (ACEIs), direct renin inhibitors (aliskiren)",EMEA/H/A-31/1370,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),Risk minimisation measures,16/05/2013,10/04/2014,,22/05/2014,04/09/2014,17/05/2013,08/10/2014,https://www.ema.europa.eu/en/medicines/human/referrals/renin-angiotensin-system-ras-acting-agents
Human,Diacerein-containing medicines for oral administration,diacerein,European Commission final decision,No,Article 31 referrals,,Zondar,-,EMEA/H/A-31/1349,,PRAC-CMDh,Nationally authorised product(s),Variation,29/11/2012,06/03/2014,23/07/2014,,04/09/2014,30/11/2012,19/09/2014,https://www.ema.europa.eu/en/medicines/human/referrals/diacerein-containing-medicines-oral-administration
Human,Protelos and Osseor,strontium ranelate,European Commission final decision,No,Article 20 procedures,,,,EMEA/H/A20/1371/C/00560-561/0039-0034,,PRAC-CHMP-EC,Centrally authorised product(s),Variation,16/05/2013,09/01/2014,,20/02/2014,15/04/2014,17/05/2013,18/09/2014,https://www.ema.europa.eu/en/medicines/human/referrals/protelos-osseor
Human,Linoladiol N and Linoladiol HN,estradiol,European Commission final decision,Yes,Article 31 referrals,,,hormonal,EMEA/H/A-31/1336,,,,,,,,25/04/2014,19/08/2014,20/12/2013,11/09/2014,https://www.ema.europa.eu/en/medicines/human/referrals/linoladiol-n-linoladiol-hn
Human,Domperidone-containing medicines,domperidone,European Commission final decision,No,Article 31 referrals,,,-,EMEA/H/A-31/1365,,PRAC-CMDh,Nationally authorised product(s),Variation,07/03/2013,06/06/2014,24/04/2014,,01/09/2014,08/03/2013,11/09/2014,https://www.ema.europa.eu/en/medicines/human/referrals/domperidone-containing-medicines
Human,Seroquel / Seroquel XR and associated names,quetiapine,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1362,,,,,,,,22/05/2014,06/08/2014,23/05/2014,09/09/2014,https://www.ema.europa.eu/en/medicines/human/referrals/seroquel-seroquel-xr-associated-names
Veterinary,Veterinary medicinal products containing tylosin to be administered orally via feed or the drinking water to pigs,tylosin,European Commission final decision,No,,,,,EMEA/V/A/100,,,,,,,,08/05/2014,31/07/2014,05/09/2014,05/09/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/veterinary-medicinal-products-containing-tylosin-be-administered-orally-feed-or-drinking-water-pigs
Veterinary,Linco-Spectin 100 and associated names,lincomycin;spectinomycin,European Commission final decision,No,,,,,EMEA/V/A/088,,,,,,,,10/04/2014,11/07/2014,04/09/2014,04/09/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/linco-spectin-100-associated-names
Human,Dexamed and associated names,dexamfetamine,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1375,,,,,,,,22/05/2014,06/08/2014,23/05/2014,02/09/2014,https://www.ema.europa.eu/en/medicines/human/referrals/dexamed-associated-names
Veterinary,Fiprex,fipronil,European Commission final decision,No,,,,,EMEA/V/A/099,,,,,,,,09/04/2014,14/07/2014,14/08/2014,14/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/fiprex
Veterinary,Vasotop P,ramipril,European Commission final decision,No,,,,,EMEA/V/A/051,,,,,,,,08/12/2009,27/04/2010,14/08/2014,14/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/vasotop-p
Veterinary,Dectomax injectable solution and its associated names,doramectin,European Commission final decision,No,,,,,EMEA/V/A/009,,,,,,,,08/12/2004,29/03/2005,13/08/2014,13/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/dectomax-injectable-solution-its-associated-names
Veterinary,Porcimectin Injection and its associated names,ivermectin,European Commission final decision,No,,,,,EMEA/V/A/003,,,,,,,,12/06/2002,12/09/2002,13/08/2014,13/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/porcimectin-injection-its-associated-names
Veterinary,Bovimectin Injection and its associated names,ivermectin,European Commission final decision,No,,,,,EMEA/V/A/002,,,,,,,,12/06/2002,19/09/2002,13/08/2014,13/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/bovimectin-injection-its-associated-names
Veterinary,Cobactan DC and its associated names,cefquinome,European Commission final decision,No,,,,,EMEA/V/A/014,,,,,,,,20/07/2006,13/10/2006,12/08/2014,12/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/cobactan-dc-its-associated-names
Veterinary,Micotil 300 and its associated names,tilmicosin,European Commission final decision,No,,,,,EMEA/V/A/010,,,,,,,,09/11/2005,23/06/2006,12/08/2014,12/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/micotil-300-its-associated-names
Veterinary,Cobactan IV 4.5% powder and solvent for solution for injection and its associated names,cefquinome,European Commission final decision,No,,,,,EMEA/V/A/012,,,,,,,,17/05/2006,21/08/2006,12/08/2014,12/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/cobactan-iv-45-powder-solvent-solution-injection-its-associated-names
Veterinary,Eprinex pour-on and its associated names,eprinomectin,European Commission final decision,No,,,,,EMEA/V/A/008,,,,,,,,11/02/2004,11/08/2004,11/08/2014,11/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/eprinex-pour-its-associated-names
Veterinary,Orbax,orbifloxacin,European Commission final decision,No,,,,,EMEA/V/A/004,,,,,,,,15/01/2003,16/04/2003,11/08/2014,11/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/orbax
Human,Caustinerf arsenical and Yranicid arsenical,ephedrine hydrochloride;lidocaine;arsenous anhydride,European Commission final decision,No,Article 31 referrals,,,Dental pulp devitalising,EMEA/H/A-31/1382,,,,,,,,25/04/2014,11/07/2014,25/04/2014,06/08/2014,https://www.ema.europa.eu/en/medicines/human/referrals/caustinerf-arsenical-yranicid-arsenical
Veterinary,Avinew,"live Newcastle disease virus, VG/GA strain",European Commission final decision,No,,,,,EMEA/V/A/001,,,,,,,,12/09/2001,04/02/2002,05/08/2014,05/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/avinew
Veterinary,Bayovac IBR Marker Vivum,"bovine Herpes Virus type 1 (BHV-1), strain Difivac (IBR-Marker Virus, gE-negative), modified live (attenuated) virus",European Commission final decision,No,,,,,EMEA/V/A/023b/001,,,,,,,,21/01/2000,10/07/2000,05/08/2014,05/08/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/bayovac-ibr-marker-vivum
Human,Methadone medicinal products for oral use containing povidone,methadone,CMDh final position,Yes,Article 107i procedures,,,,EMEA/H/A-107i/1395,,PRAC-CMDh,Nationally authorised product(s),Suspension,10/04/2014,10/07/2014,23/07/2014,,,11/04/2014,04/08/2014,https://www.ema.europa.eu/en/medicines/human/referrals/methadone-medicinal-products-oral-use-containing-povidone
Human,Zolpidem-containing medicines,zolpidem,European Commission final decision,No,Article 31 referrals,,,,EMEA/H/A-31/1377,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,11/07/2013,06/03/2014,,24/04/2014,23/06/2014,12/07/2013,04/08/2014,https://www.ema.europa.eu/en/medicines/human/referrals/zolpidem-containing-medicines
Human,Crestor and associated names,rosuvastatin,European Commission final decision,No,Article 29 paediatrics,,,,EMEA/H/A-29-PAE/1378,,,,,,,,30/06/2014,,01/08/2014,01/08/2014,https://www.ema.europa.eu/en/medicines/human/referrals/crestor-associated-names
Human,Sandostatin LAR and associated names,ocreotide,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/001355,,,,,,,,26/06/2014,26/06/2014,27/06/2014,27/06/2014,https://www.ema.europa.eu/en/medicines/human/referrals/sandostatin-lar-associated-names
Human,Sandostatin and associated names,ocreotide,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/001354,,,,,,,,26/06/2014,26/06/2014,27/06/2014,27/06/2014,https://www.ema.europa.eu/en/medicines/human/referrals/sandostatin-associated-names
Human,Nanotop and associated names,"human albumin, denatured",European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1386,,,,,,,,19/12/2013,28/02/2014,20/12/2013,16/06/2014,https://www.ema.europa.eu/en/medicines/human/referrals/nanotop-associated-names
Human,Ketoconazole-containing medicines,ketoconazole,European Commission final decision,No,Article 31 referrals,,Nizoral  ;Fungoral,Antifungal,EMEA/H/A-31/1314,,,,,,,,25/07/2013,11/10/2013,26/07/2013,13/06/2014,https://www.ema.europa.eu/en/medicines/human/referrals/ketoconazole-containing-medicines
Veterinary,Long-acting formulations for injection containing barium selenate for all food producing species,barium selenate,European Commission final decision,No,,,,,EMEA/V/A/077,,,,,,,,06/11/2013,28/03/2014,27/05/2014,27/05/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/long-acting-formulations-injection-containing-barium-selenate-all-food-producing-species
Human,Methysergide-containing medicines,methysergide,European Commission final decision,No,Article 31 referrals,,Deseril  ;Desernil,Ergot alkaloids,EMEA/H/A-31/1335,,,,,,,,20/02/2014,28/04/2014,21/02/2014,27/05/2014,https://www.ema.europa.eu/en/medicines/human/referrals/methysergide-containing-medicines
Human,Rocephin,Ceftriaxone,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1302,,,,,,,,23/01/2014,21/03/2014,24/01/2014,19/05/2014,https://www.ema.europa.eu/en/medicines/human/referrals/rocephin
Veterinary,Norbonex 5 mg/ml pour-on solution for beef and dairy cattle,eprinomectin,European Commission final decision,No,,,,,EMEA/V/A/098,,,,,,,,15/01/2014,21/03/2014,14/05/2014,14/05/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/norbonex-5-mg-ml-pour-solution-beef-dairy-cattle
Veterinary,Veterinary medicines containing enrofloxacin to be administered via the drinking water to chickens and/or turkeys,enrofloxacin,European Commission final decision,No,,,,,EMEA/V/A/089,,,,,,,,07/11/2013,28/02/2014,10/04/2014,10/04/2014,https://www.ema.europa.eu/en/medicines/veterinary/referrals/veterinary-medicines-containing-enrofloxacin-be-administered-drinking-water-chickens-or-turkeys
Human,Kogenate Bayer and Helixate NexGen,octocog alfa,European Commission final decision,No,Article 20 procedures,,,-,"EMEA/H/C/275/A20/150, EMEA/H/C/276/A20/143",,PRAC-CHMP-EC,Centrally authorised product(s),Variation,07/03/2013,05/12/2013,,19/12/2013,20/02/2014,08/03/2013,09/04/2014,https://www.ema.europa.eu/en/medicines/human/referrals/kogenate-bayer-helixate-nexgen
Human,Tibolona Aristo and Tibocina and associated names,tibolone,European Commission final decision,No,Article 29(4) referrals,,Tibolon Aristo  ;Tibolinia,,EMEA/H/A-29/1389 and EMEA/H/A-29/1390,,,,,,,,19/12/2013,05/03/2014,20/12/2013,08/04/2014,https://www.ema.europa.eu/en/medicines/human/referrals/tibolona-aristo-tibocina-associated-names
Human,Valebo and associated names,alendronic acid;alfacalcidol,European Commission final decision,No,Article 29(4) referrals,,Tevabone  ;Teboneva,,EMEA/H/A-29/1364,,,,,,,,19/12/2013,10/03/2014,20/12/2013,31/03/2014,https://www.ema.europa.eu/en/medicines/human/referrals/valebo-associated-names
Human,Valtrex,valaciclovir,European Commission final decision,No,Article 30 referrals,,Zelitrex  ;Talavir  ;Valaciclovir Allen  ;Valherpes,,EMEA/H/A-30/1004,,,,,,,,22/04/2010,13/07/2010,23/04/2010,25/03/2014,https://www.ema.europa.eu/en/medicines/human/referrals/valtrex
Human,Substances related to nicotinic acid,acipimox,European Commission final decision,No,Article 31 referrals,,Olbetam,Lipid-lowering agents,EMEA/H/A-31/1366,,PRAC-CMDh,Nationally authorised product(s),Variation,07/03/2013,07/11/2013,18/12/2013,,20/02/2014,08/03/2013,13/03/2014,https://www.ema.europa.eu/en/medicines/human/referrals/substances-related-nicotinic-acid
Human,"Monovalent and multivalent measles, mumps, rubella and / or varicella vaccines","monovalent and multivalent measles, mumps, rubella and varicella vaccines (live)",European Commission final decision,Yes,Article 31 referrals,,Amunovax  ;Priorix  ;Priorix Tetra  ;Provarivax  ;R.O.R. Vax  ;Rouvax  ;Trivivac  ;Varilrix  ;Varivax,Vaccines,EMEA/H/A-31/1333,,,,,,,,13/12/2012,27/06/2013,14/12/2012,12/03/2014,https://www.ema.europa.eu/en/medicines/human/referrals/monovalent-multivalent-measles-mumps-rubella-or-varicella-vaccines
Human,Intravenous nicardipine medicines,nicardipine,European Commission final decision,No,Article 31 referrals,,Cardene IV  ;Loxen  ;Nicardipine Aguettant  ;Nicardipine Arrow  ;Rydene  ;Vasonase,Antihypertensive,EMEA/H/A-31/1339,,,,,,,,24/10/2013,20/12/2013,25/10/2013,12/03/2014,https://www.ema.europa.eu/en/medicines/human/referrals/intravenous-nicardipine-medicines
Human,Hydroxyethyl starch solutions for infusion,hydroxyethyl starch,European Commission final decision,Yes,Article 107i procedures,,,,EMEA/H/A-107i/1376,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,11/07/2013,10/10/2013,,23/10/2013,19/12/2013,12/07/2013,06/03/2014,https://www.ema.europa.eu/en/medicines/human/referrals/hydroxyethyl-starch-solutions-infusion-0
Human,Thiocolchicoside-containing medicines,thiocolchicoside,European Commission final decision,No,Article 31 referrals,,Muscoril and Coltramyl,muscle relaxant,EMA/H/A-31/1361,,,,,,,,21/11/2013,17/01/2014,22/11/2013,06/03/2014,https://www.ema.europa.eu/en/medicines/human/referrals/thiocolchicoside-containing-medicines
Human,Ergot derivatives,dihydroergocristine;dihydroergotamine;dihydroergotoxine;nicergoline;dihydroergocryptine;caffeine,European Commission final decision,No,Article 31 referrals,,,Ergot derivatives,EMEA/H/A-31/1325,,,,,,,,27/06/2013,27/09/2013,28/06/2013,17/02/2014,https://www.ema.europa.eu/en/medicines/human/referrals/ergot-derivatives
Human,Metoclopramide-containing medicines,metoclopramide,European Commission final decision,No,Article 31 referrals,,Maxolon  ;Primperan,Anti-emetic,EMEA/H/A-31/1321,,,,,,,,24/10/2013,20/12/2013,26/07/2013,06/02/2014,https://www.ema.europa.eu/en/medicines/human/referrals/metoclopramide-containing-medicines
Human,Combined hormonal contraceptives,desogestrel;gestodene;norgestimate;etonogestrel;drospirenone;dienogest;chlormadinone;nomegestrol;norelgestromin,European Commission final decision,No,Article 31 referrals,,,-,EMEA/H/A-31/1356,,PRAC-CHMP-EC,Centrally and nationally authorised products (mixed),Risk minimisation measures,07/02/2013,10/10/2013,,16/01/2014,,08/02/2013,31/01/2014,https://www.ema.europa.eu/en/medicines/human/referrals/combined-hormonal-contraceptives
Human,Okrido,prednisolone sodium phosphate,European Commission final decision,No,Article 29(4) referrals,,,-,EMEA/H/A-29/1368,,,,,,,,27/06/2013,05/09/2013,28/06/2013,03/01/2014,https://www.ema.europa.eu/en/medicines/human/referrals/okrido
Human,Targocid and associated names,teicoplanin,European Commission final decision,No,Article 30 referrals,,Targocid  ;Teicomid,-,EMEA/H/A-30/1301,,,,,,,,30/05/2013,12/09/2013,31/05/2013,03/01/2014,https://www.ema.europa.eu/en/medicines/human/referrals/targocid-associated-names
Human,Sandimmun and associated names,ciclosporin,European Commission final decision,No,Article 30 referrals,,,,"EMEA/H/A-30/1300, EMEA/H/A-30/1320",,,,,,,,27/06/2013,31/10/2013,28/06/2013,20/12/2013,https://www.ema.europa.eu/en/medicines/human/referrals/sandimmun-associated-names
Human,Sandimmun Neoral and associated names,ciclosporin,European Commission final decision,No,Article 30 referrals,,,,"EMEA/H/A-30/1300, EMEA/H/A-30/1320",,,,,,,,27/06/2013,31/10/2013,28/06/2013,20/12/2013,https://www.ema.europa.eu/en/medicines/human/referrals/sandimmun-neoral-associated-names
Human,Didanosine,didanosine,European Commission final decision,No,Article 29(4) referrals,,,-,EMEA/H/A-29/1367,,,,,,,,19/09/2013,20/11/2013,20/09/2013,10/12/2013,https://www.ema.europa.eu/en/medicines/human/referrals/didanosine
Human,Methylphenidate Sandoz,methylphenidate hydrochloride,European Commission final decision,No,Article 29(4) referrals,,,-,EMEA/H/A-29/1359,,,,,,,,25/07/2013,09/10/2013,26/07/2013,05/12/2013,https://www.ema.europa.eu/en/medicines/human/referrals/methylphenidate-sandoz
Human,Methylphenidate Hexal,methylphenidate hydrochloride,European Commission final decision,No,Article 29(4) referrals,,,-,EMEA/H/A-29/1360,,,,,,,,25/07/2013,09/10/2013,26/07/2013,05/12/2013,https://www.ema.europa.eu/en/medicines/human/referrals/methylphenidate-hexal
Human,Diclofenac-containing medicines,diclofenac,European Commission final decision,No,Article 31 referrals,,,Non-steroidal anti-inflammatory drugs (NSAIDs),EMEA/H/A-31/1344,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,31/10/2012,13/06/2013,26/06/2013,,25/09/2013,31/10/2012,27/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/diclofenac-containing-medicines
Veterinary,Dexadreson,dexamethasone,European Commission final decision,No,,,,,EMEA/V/A/087,,,,,,,,18/07/2013,18/10/2013,27/11/2013,27/11/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/dexadreson
Human,Flupirtine-containing medicines,flupirtine,European Commission final decision,Yes,Article 107i procedures,,,-,EMEA/H/A-107i/1363,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,07/03/2013,13/06/2013,26/06/2013,,05/09/2013,08/03/2013,21/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/flupirtine-containing-medicines
Veterinary,Micotil 300 Injectie,tilmicosin,European Commission final decision,No,,,,,EMEA/V/A-34/82,,,,,,,,18/07/2013,18/10/2013,20/11/2013,20/11/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/micotil-300-injectie
Human,Baxter dialysis solutions,,European Commission final decision,Yes,Article 31 referrals,,,dialysis solutions,EMEA/H/A-31/1290,,,,,,,,20/10/2011,16/12/2011,23/09/2011,20/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/baxter-dialysis-solutions
Human,Ciclosporin IDL,ciclosporin,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1105,,,,,,,,18/03/2010,22/07/2010,23/07/2009,20/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/ciclosporin-idl
Human,Tazocin,piperacillin;tazobactam,European Commission final decision,No,Article 30 referrals,,Tazobac  ;Tazocel  ;Tazonam,,EMEA/H/A-30/001149,,,,,,,,21/10/2010,21/02/2011,22/10/2010,19/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/tazocin
Human,Avalox,moxifloxacin,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1082,,,,,,,,25/06/2009,02/10/2009,25/06/2009,19/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/avalox
Human,Vivaglobin,human normal immunoglobulin,European Commission final decision,No,Article 36 referrals (prior to July 2012),,,-,EMEA/H/A-36/1296,,,,,,,,16/02/2012,07/05/2012,17/02/2012,18/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/vivaglobin
Human,Octagam,human normal immunoglobulin,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,,-,EMEA/H/A-107/001278,,,,,,,,23/09/2010,04/10/2010,24/09/2010,18/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/octagam-0
Human,Augmentin,amoxicillin;clavulanic acid,European Commission final decision,No,Article 30 referrals,,,-,CHMP/97898/2009,,,,,,,,19/01/2009,19/10/2009,25/06/2009,18/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/augmentin
Human,Short-acting beta-agonists,terbutaline;salbutamol;hexoprenaline;ritodrine;fenoterol;isoxsuprine,CMDh final position,No,Article 31 referrals,,,-,EMEA/H/A-31/1347,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,27/11/2012,05/09/2013,23/10/2013,,,30/11/2012,07/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/short-acting-beta-agonists
Human,Antifibrinolytic medicines,aprotinin;aminocaproic acid;tranexamic acid,European Commission final decision,Yes,Article 31 referrals,,,"B02A, Antihemorrhagics",EMEA/H/A-31/1267,,,,,,,,19/06/2012,,17/02/2012,06/11/2013,https://www.ema.europa.eu/en/medicines/human/referrals/antifibrinolytic-medicines
Veterinary,Suifertil 4-mg/ml oral solution for pigs and associated names,altrenogest,European Commission final decision,No,,,,,EMEA/V/A/094,,,,,,,,18/07/2013,02/10/2013,30/10/2013,30/10/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/suifertil-4-mg-ml-oral-solution-pigs-associated-names
Veterinary,Cydectin TriclaMox,moxidectin;triclabendazole,European Commission final decision,No,,,,,EMEA/V/A/096,,,,,,,,16/07/2013,25/09/2013,18/10/2013,18/10/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/cydectin-triclamox
Veterinary,Doramectin,doramectin,European Commission final decision,No,,,,-,EMEA/V/A/081,,,,,,,,12/06/2013,06/09/2013,18/10/2013,18/10/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/doramectin
Veterinary,Deltanil,deltamethrin,European Commission final decision,No,,,,,EMEA/V/A/093,,,,,,,,24/09/2013,24/09/2013,11/10/2013,11/10/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/deltanil
Human,Numeta G13%E and Numeta G16%E emulsion for infusion,,CMDh final position,Yes,Article 107i procedures,,,-,EMEA/H/A-107i/1373,,PRAC-CMDh,Nationally authorised product(s),Suspension,13/06/2013,05/09/2013,,18/09/2013,,14/06/2013,27/09/2013,https://www.ema.europa.eu/en/medicines/human/referrals/numeta-g13e-numeta-g16e-emulsion-infusion
Veterinary,Soludox,doxycycline hyclate,European Commission final decision,No,,,,,EMEA/V/A/090,,,,,,,,12/06/2013,12/08/2013,24/09/2013,24/09/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/soludox
Veterinary,Strenzen 500/125-mg/g powder,amoxicillin;clavulanic acid,European Commission final decision,No,,,,,EMEA/V/A/085,,,,,,,,10/04/2013,12/08/2013,19/09/2013,19/09/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/strenzen-500-125-mg-g-powder
Human,Cilostazol-containing medicines,cilostazol,European Commission final decision,No,Article 31 referrals,,Pletal  ;Ekistol,antiplatelet agents,EMEA/H/A-31/1306,,,,,,,,21/03/2013,24/06/2013,22/03/2013,11/09/2013,https://www.ema.europa.eu/en/medicines/human/referrals/cilostazol-containing-medicines
Human,Cyproterone- and ethinylestradiol-containing medicines,cyproterone;ethinyl estradiol,European Commission final decision,Yes,Article 107i procedures,,Acnemine  ;Acneson  ;Chloe  ;Clairette  ;Cyprest  ;Cyprodiol  ;Diane 35  ;Dianette  ;Feminil  ;Minerva  ;Zyrona,,EMEA/H/A-107i/1357,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,07/02/2013,16/05/2013,29/05/2013,,25/07/2013,08/02/2013,05/08/2013,https://www.ema.europa.eu/en/medicines/human/referrals/cyproterone-ethinylestradiol-containing-medicines
Human,Codeine-containing medicines,codeine,CMDh final position,No,Article 31 referrals,,,-,EMEA/H/A-31/1342,,PRAC-CMDh,Nationally authorised product(s),Risk minimisation measures,03/10/2012,13/06/2013,26/06/2013,,,05/10/2012,02/08/2013,https://www.ema.europa.eu/en/medicines/human/referrals/codeine-containing-medicines
Human,Furosemide Vitabalans,furosemide,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1334,,,,,,,,18/02/2013,14/05/2013,22/02/2013,30/07/2013,https://www.ema.europa.eu/en/medicines/human/referrals/furosemide-vitabalans
Human,Simvastatin Vale,simvastatin,European Commission final decision,No,Article 29(4) referrals,,Simvastatin Vale pharmaceuticals,Statin,EMEA/H/A-29/1358,,,,,,,,25/03/2013,27/05/2013,03/04/2013,22/07/2013,https://www.ema.europa.eu/en/medicines/human/referrals/simvastatin-vale
Human,Calcitonin,calcitonin,European Commission final decision,Yes,Article 31 referrals,,,,EMEA/H/A-31/1291,,,,,,,,19/07/2012,13/02/2013,20/07/2012,19/07/2013,https://www.ema.europa.eu/en/medicines/human/referrals/calcitonin
Human,Tetrazepam-containing medicines,tetrazepam,European Commission final decision,Yes,Article 107i procedures,,Myolastan and generics,-,EMEA/H/A107i/1352,,PRAC-CMDh,Nationally authorised product(s),Suspension,10/01/2013,11/04/2013,24/04/2013,,29/05/2013,11/01/2013,18/07/2013,https://www.ema.europa.eu/en/medicines/human/referrals/tetrazepam-containing-medicines
Veterinary,Florgane,florfenicol,European Commission final decision,No,,,,,EMEA/V/A/083,,,,,,,,06/03/2013,23/05/2013,10/07/2013,10/07/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/florgane
Veterinary,Nuflor Swine Once,florfenicol,European Commission final decision,No,,,,-,EMEA/V/A/080,,,,,,,,07/02/2013,16/05/2013,14/06/2013,14/06/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/nuflor-swine-once
Human,Almitrine-containing medicines,almitrine,CMDh final position,No,Article 31 referrals,,Vectarion  ;Armanor,,EMEA/H/A-31/1346,,PRAC-CMDh,Nationally authorised product(s),Suspension,29/11/2012,16/05/2013,29/05/2013,,,30/11/2012,10/06/2013,https://www.ema.europa.eu/en/medicines/human/referrals/almitrine-containing-medicines
Human,"Tredaptive, Pelzont and Trevaclyn",laropiprant;nicotinic acid,European Commission final decision,No,Article 20 procedures,,,cardiovascular,"EMEA/H/C/889/A20/37, EMEA/H/C/903/A20/38, EMEA/H/C/897/A20/38",,PRAC-CHMP-EC,Centrally authorised product(s),Suspension,20/12/2012,10/01/2013,,,22/03/2013,21/12/2012,17/05/2013,https://www.ema.europa.eu/en/medicines/human/referrals/tredaptive-pelzont-trevaclyn
Human,Kantos Master,beclometasone dipropionate;formoterol fumarate,European Commission final decision,No,Article 13 referrals,,Kantos  ;Formodual  ;Foster  ;Inuxair  ;Innovair and associated names,-,EMEA/H/A-13/1350,,,,,,,,17/01/2013,10/04/2013,18/01/2013,02/05/2013,https://www.ema.europa.eu/en/medicines/human/referrals/kantos-master
Human,Fibrates,bezafibrate;ciprofibrate;fenofibrate;gemfibrozil,European Commission final decision,No,Article 31 referrals,,Bezalip  ;Lipanor  ;Lipanthyl  ;Lopid,fibrates,EMEA/H/A-31/001238,,,,,,,,21/10/2010,28/02/2011,22/10/2010,03/04/2013,https://www.ema.europa.eu/en/medicines/human/referrals/fibrates
Human,Fibrinogen-containing solutions for sealant authorised for administration by spray application,fibrin,European Commission final decision,No,Article 31 referrals,Evicel,Quixil,Fibrin sealants,EMEA/H/A-31/1337,,,,,,,,15/11/2012,13/02/2013,16/11/2012,02/04/2013,https://www.ema.europa.eu/en/medicines/human/referrals/fibrinogen-containing-solutions-sealant-authorised-administration-spray-application-0
Human,Fibrinogen-containing solutions for sealant authorised for administration by spray application,fibrin,European Commission final decision,No,Article 31 referrals,,Tisseel  ;Tissucol  ;Artiss  ;Beriplast P,Fibrin sealants,EMEA/H/A-31/1337,,,,,,,,13/12/2012,15/03/2013,14/12/2012,02/04/2013,https://www.ema.europa.eu/en/medicines/human/referrals/fibrinogen-containing-solutions-sealant-authorised-administration-spray-application
Human,Tolperisone,tolperisone,European Commission final decision,Yes,Article 31 referrals,,,-,EMEA/H/A-31/1311,,,,,,,,18/10/2012,21/01/2013,22/06/2012,02/04/2013,https://www.ema.europa.eu/en/medicines/human/referrals/tolperisone
Veterinary,Melosolute,meloxicam,European Commission final decision,No,,,,,EMEA/V/A/084,,,,,,,,08/11/2012,12/02/2013,15/03/2013,15/03/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/melosolute
Human,Medicines studied at Cetero Research facility,fenofibrate;cilazapril;leflunomide,European Commission final decision,No,Article 31 referrals,,Cilazapril Teva  ;Fenofibrato Pensa  ;Fenofibrato Ranbaxy  ;Leflunomide Actavis  ;Leflunomide Apotex,-,EMEA/H/A-31/001340,,,,,,,,13/12/2012,20/02/2013,14/12/2012,12/03/2013,https://www.ema.europa.eu/en/medicines/human/referrals/medicines-studied-cetero-research-facility
Human,Loraxin,loratadine,European Commission final decision,No,Article 29(4) referrals,,,-,EMEA/H/A-29/1325,,,,,,,,18/10/2012,20/12/2012,22/06/2012,28/02/2013,https://www.ema.europa.eu/en/medicines/human/referrals/loraxin
Veterinary,Hipralona Enro-S,enrofloxacin,European Commission final decision,No,,,,-,EMEA/V/A/079,,,,,,,,13/09/2012,17/12/2012,04/02/2013,04/02/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/hipralona-enro-s
Human,Zinacef,cefuroxime sodium,European Commission final decision,No,Article 30 referrals,,Curocef  ;Curoxim  ;Curoxim Monovial  ;Curoxima  ;Curoxime  ;Zinnat  ;Zinocep  ;Zinocep Vena,Anti-infectives,EMEA/H/A-30/1158,,,,,,,,24/05/2012,10/09/2012,25/05/2012,29/01/2013,https://www.ema.europa.eu/en/medicines/human/referrals/zinacef
Human,Zinnat,cefuroxime axetil,European Commission final decision,No,Article 30 referrals,,Cefuroxima Solasma  ;Cefuroxima Allen  ;Cefuroxima Duncan  ;Elobact  ;Nivador  ;Oraxim  ;Selan  ;Tilexim  ;Zinadol  ;Zipos  ;Zoref,Anti-infectives,EMEA/H/A-30/1157,,,,,,,,24/05/2012,23/08/2012,25/05/2012,29/01/2013,https://www.ema.europa.eu/en/medicines/human/referrals/zinnat
Human,Mometasone Furoate Sandoz,mometasone furoate,European Commission final decision,No,Article 29(4) referrals,,Mometasone Sandoz  ;Mometasone Sandoz 50  ;Mometasone Furoato Sandoz 50  ;Mommox  ;Nasometi  ;Fumomo 50,Glucocorticoids,EMEA/H/A-29/1332,,,,,,,,19/07/2012,08/10/2012,20/07/2012,24/01/2013,https://www.ema.europa.eu/en/medicines/human/referrals/mometasone-furoate-sandoz
Veterinary,Flukicides for which no maximum residue limit has been established in milk and which are intended for use in ruminants producing milk for human consumption,clorsulon;closantel;nitroxinil;rafoxanide;triclabendazole,European Commission final decision,No,,,,-,EMEA/V/A/069,,,,,,,,14/06/2012,19/11/2012,18/01/2013,18/01/2013,https://www.ema.europa.eu/en/medicines/veterinary/referrals/flukicides-which-no-maximum-residue-limit-has-been-established-milk-which-are-intended-use-ruminants-producing-milk-human-consumption
Human,Ethinylestradiol-Drospirenone 24+4,ethinyl estradiol;drospirenone,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,Yaz 24+4,,EMEA/H/A-6(12)/1313,,,,,,,,19/04/2012,06/07/2012,20/04/2012,11/01/2013,https://www.ema.europa.eu/en/medicines/human/referrals/ethinylestradiol-drospirenone-244
Human,Yaz 24+4,ethinylestradiol;drospirenone,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,Ethinylestradiol-Drospirenone 24+4,,EMEA/H/A-6(12)/1312,,,,,,,,19/04/2012,03/07/2012,20/04/2012,11/01/2013,https://www.ema.europa.eu/en/medicines/human/referrals/yaz-244
Human,Mifepristone Linepharma,mifepristone,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1331,,,,,,,,21/06/2012,11/09/2012,22/06/2012,03/01/2013,https://www.ema.europa.eu/en/medicines/human/referrals/mifepristone-linepharma
Human,Yvidually,ethinylestradiol;drospirenone,European Commission final decision,No,Article 29(4) referrals,,Flexyess,,EMEA/H/A-29/1330,,,,,,,,19/04/2012,28/09/2012,20/04/2012,03/01/2013,https://www.ema.europa.eu/en/medicines/human/referrals/yvidually
Human,Orlistat,orlistat,European Commission final decision,Yes,Article 31 referrals,,,-,EMEA/H/A-31/1318,,,,,,,,16/02/2012,24/04/2012,16/02/2012,21/12/2012,https://www.ema.europa.eu/en/medicines/human/referrals/orlistat
Human,Glimepirida Parke-Davis,glimepiride,European Commission final decision,No,Article 29(4) referrals,,Glimepiride Pfizer  ;Glimepirid Pfizer  ;Glimepiride tablets 2 mg  ;Glimepiride tablets 3 mg  ;Glimepiride tablets 4 mg,"Sulfonamides, urea derivatives",EMEA/H/A-29/1338,,,,,,,,19/07/2012,19/11/2012,20/07/2012,06/12/2012,https://www.ema.europa.eu/en/medicines/human/referrals/glimepirida-parke-davis
Veterinary,Baytril 10% oral solution,enrofloxacin,European Commission final decision,No,,,,,EMEA/V/A/067,,,,,,,,14/06/2012,08/10/2012,20/11/2012,20/11/2012,https://www.ema.europa.eu/en/medicines/veterinary/referrals/baytril-10-oral-solution
Human,Iffeza,fluticasone propionate;formoterol fumarate,European Commission final decision,No,Article 29(4) referrals,,Flutiform  ;Flofera  ;Flutiformo,,EMEA/H/A-29/001327,,,,,,,,19/04/2012,28/06/2012,20/04/2012,25/10/2012,https://www.ema.europa.eu/en/medicines/human/referrals/iffeza
Human,Flutiform,fluticasone propionate;formoterol fumarate,European Commission final decision,No,Article 29(4) referrals,,Iffeza  ;Flofera  ;Flutiformo,,EMEA/H/A-29/001326,,,,,,,,19/04/2012,28/06/2012,20/04/2012,25/10/2012,https://www.ema.europa.eu/en/medicines/human/referrals/flutiform
Veterinary,Nuflor,florfenicol,European Commission final decision,No,,,,,EMEA/V/A/078,,,,,,,,12/06/2012,17/09/2012,19/10/2012,19/10/2012,https://www.ema.europa.eu/en/medicines/veterinary/referrals/nuflor
Human,Trimetazidine,trimetazidine,European Commission final decision,Yes,Article 31 referrals,,Vastarel,,EMEA/H/A-31/1305,,,,,,,,21/06/2012,03/09/2012,22/06/2012,17/10/2012,https://www.ema.europa.eu/en/medicines/human/referrals/trimetazidine
Human,Flolan,epoprostenol,European Commission final decision,No,Article 30 referrals,,Epoprostenol,,EMEA/H/A-30/1299,,,,,,,,24/05/2012,08/08/2012,25/05/2012,14/09/2012,https://www.ema.europa.eu/en/medicines/human/referrals/flolan
Human,Tavanic,levofloxacin,European Commission final decision,No,Article 30 referrals,,Levofloxacin,,EMEA/H/A-30/1262,,,,,,,,24/05/2012,31/07/2012,25/05/2012,12/09/2012,https://www.ema.europa.eu/en/medicines/human/referrals/tavanic
Veterinary,Milaxyn Plus,praziquantel;pyrantel;febantel,European Commission final decision,No,,,,,EMEA/V/A/076,,,,,,,,07/03/2012,18/06/2012,23/07/2012,23/07/2012,https://www.ema.europa.eu/en/medicines/veterinary/referrals/milaxyn-plus
Human,Valproat Ratiopharm Chrono,valproic acid;valproate,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,EMEA/H/A-6(12)/1147,,,,,,,,25/05/2010,26/05/2010,23/07/2012,23/07/2012,https://www.ema.europa.eu/en/medicines/human/referrals/valproat-ratiopharm-chrono
Human,Preflucel,"influenza vaccine, purified antigen",European Commission final decision,No,Article 36 referrals (prior to July 2012),,,,EMEA/H/A-36/1323,,,,,,,,19/07/2012,10/12/2012,20/07/2012,20/07/2012,https://www.ema.europa.eu/en/medicines/human/referrals/preflucel
Veterinary,"All pre-mixes for medicated feedingstuff containing 40 g, 100 g or 200 g tilmicosin per kg pre-mix and administered to rabbits",tilmicosin,European Commission final decision,No,,,,,EMEA/V/A/071,,,,,,,,07/03/2012,14/06/2012,19/07/2012,19/07/2012,https://www.ema.europa.eu/en/medicines/veterinary/referrals/all-pre-mixes-medicated-feedingstuff-containing-40-g-100-g-or-200-g-tilmicosin-kg-pre-mix-administered-rabbits
Veterinary,Prontax 5 mg/ml pour-on solution for cattle,doramectin,European Commission final decision,No,,,,,EMEA/V/074,,,,,,,,08/02/2012,25/05/2012,05/07/2012,05/07/2012,https://www.ema.europa.eu/en/medicines/veterinary/referrals/prontax-5-mg-ml-pour-solution-cattle
Veterinary,"Prontax 10 mg/ml solution for injection for cattle, sheep and pigs",doramectin,European Commission final decision,No,,,,,EMEA/V/A-73,,,,,,,,08/02/2012,25/05/2012,05/07/2012,05/07/2012,https://www.ema.europa.eu/en/medicines/veterinary/referrals/prontax-10-mg-ml-solution-injection-cattle-sheep-pigs
Human,Docetaxel Teva Generics,docetaxel,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/001277,,,,,,,,17/02/2011,07/07/2011,18/02/2011,03/07/2012,https://www.ema.europa.eu/en/medicines/human/referrals/docetaxel-teva-generics
Human,Priorix,"measles, mumps and rubella vaccine (live)",European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1283,,,,,,,,15/03/2012,25/05/2012,16/03/2012,19/06/2012,https://www.ema.europa.eu/en/medicines/human/referrals/priorix
Human,Buflomedil,buflomedil,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,,vasoactive agent,EMEA/H/A-107/1293,,,,,,,,17/11/2011,13/02/2012,20/05/2011,13/06/2012,https://www.ema.europa.eu/en/medicines/human/referrals/buflomedil
Human,Femara,letrozole,European Commission final decision,No,Article 30 referrals,,Femar  ;Fémara  ;Loxifan,,EMEA/H/A-30/1264,,,,,,,,15/03/2012,22/05/2012,16/03/2012,12/06/2012,https://www.ema.europa.eu/en/medicines/human/referrals/femara
Human,Meprobamate,meprobamate,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Equanil and other trade names,,EMEA/H/A-107/1316,,,,,,,,19/01/2012,30/03/2012,20/01/2011,08/06/2012,https://www.ema.europa.eu/en/medicines/human/referrals/meprobamate
Human,Galantamine Stada,galantamine,European Commission final decision,No,Article 29(4) referrals,,Galantamina  ;Galantamine Tiefenbacher  ;Galantamina Ciclum  ;Galatnax xl  ;Galastad,,EMEA/H/A-29/001268,,,,,,,,23/09/2010,21/02/2011,24/09/2010,08/06/2012,https://www.ema.europa.eu/en/medicines/human/referrals/galantamine-stada
Human,Somatropin,somatropin,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Genotropin  ;Humatrope  ;Maxomat  ;Norditropin  ;Saizen  ;Zomacton,,EMEA/H/A-107/001287,,,,,,,,15/12/2011,27/02/2012,15/12/2011,23/04/2012,https://www.ema.europa.eu/en/medicines/human/referrals/somatropin
Human,Nimesulide,nimesulide,European Commission final decision,Yes,Article 31 referrals,,,,EMEA/H/A-31/001261,,,,,,,,23/06/2011,20/01/2012,23/06/2011,19/04/2012,https://www.ema.europa.eu/en/medicines/human/referrals/nimesulide-1
Human,Norditropin,somatropin,European Commission final decision,No,Article 13 referrals,,Norditropin FlexPro  ;Norditropin NordiFlex  ;Norditropin SimpleXx,,EMEA/H/A-13/1304,,,,,,,,15/12/2011,06/03/2012,16/12/2011,19/04/2012,https://www.ema.europa.eu/en/medicines/human/referrals/norditropin-0
Human,Terpenic derivatives,"camphor;cineole;niaouli;wild thyme;terpineol;terpine;citral;menthol;essential oils of pine needle, eucalyptus and turpentine",European Commission final decision,Yes,Article 31 referrals,,,Terpenic derivatives,EMA/CHMP/763180/2011,,,,,,,,17/11/2011,20/01/2012,23/09/2011,13/04/2012,https://www.ema.europa.eu/en/medicines/human/referrals/terpenic-derivatives
Human,Lipitor,atorvastatin,European Commission final decision,No,Article 30 referrals,,Atorvastatin  ;Atorvastatina Nostrum  ;Atorvastatina Parke-Davis  ;Atorvastatina Pharmacia  ;Cardyl  ;Edovin  ;Liprimar  ;Orbeos  ;Prevencor  ;Sortis  ;Tahor  ;Texzor  ;Torvast  ;Totalip  ;Xarator  ;Zarator,,EMEA/H/A-30/001154,,,,,,,,23/09/2010,13/12/2010,24/09/2010,10/04/2012,https://www.ema.europa.eu/en/medicines/human/referrals/lipitor
Human,Norvasc,amlodipine,European Commission final decision,No,Article 30 referrals,,Amlodipine Pfizer  ;Amlodipino  ;Amlor  ;Istin  ;Monopina,,EMEA/H/A-30/1288,,,,,,,,21/07/2011,07/10/2011,22/07/2011,29/03/2012,https://www.ema.europa.eu/en/medicines/human/referrals/norvasc
Human,Pholcodine,pholcodine,European Commission final decision,Yes,Article 31 referrals,,,,EMEA/H/A-31/1292,,,,,,,,15/12/2011,17/02/2012,18/11/2011,28/03/2012,https://www.ema.europa.eu/en/medicines/human/referrals/pholcodine
Human,Priligy,dapoxetine,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1294,,,,,,,,20/10/2011,20/01/2012,21/01/2011,28/03/2012,https://www.ema.europa.eu/en/medicines/human/referrals/priligy
Human,Tienam,imipenem;cilastatin,European Commission final decision,No,Article 30 referrals,,Conet  ;Imipem  ;Primaxin  ;Tenacid  ;Zienam,,EMEA/H/A-30/001187,,,,,,,,16/12/2010,10/03/2011,17/12/2010,20/02/2012,https://www.ema.europa.eu/en/medicines/human/referrals/tienam
Human,Canazole,clotrimazole,European Commission final decision,No,Article 29(4) referrals,,Canesten,,EMEA/H/A-29/1286,,,,,,,,17/03/2011,22/09/2011,18/03/2011,09/02/2012,https://www.ema.europa.eu/en/medicines/human/referrals/canazole
Human,Novimp,goserelin,European Commission final decision,No,Article 36 referrals (prior to July 2012),,,,EMEA/H/A-36/1298,,,,,,,,23/06/2011,16/09/2011,06/02/2012,06/02/2012,https://www.ema.europa.eu/en/medicines/human/referrals/novimp
Human,Novosis Goserelin,goserelin,European Commission final decision,No,Article 36 referrals (prior to July 2012),,Goserelin Novosis  ;Gosacin,,EMEA/H/A-36/1295,,,,,,,,23/06/2011,16/09/2011,06/02/2012,06/02/2012,https://www.ema.europa.eu/en/medicines/human/referrals/novosis-goserelin
Human,Goserelin Cell Pharm,goserelin,European Commission final decision,No,Article 36 referrals (prior to July 2012),,Novosis Goserelin  ;Goserelin Cell Pharm  ;Novimp and associated names,,EMEA/H/A-36/1297,,,,,,,,23/06/2011,16/09/2011,24/06/2011,06/02/2012,https://www.ema.europa.eu/en/medicines/human/referrals/goserelin-cell-pharm
Veterinary,Clavudale 50mg tablet for cats and dogs,amoxicillin;clavulanic acid,European Commission final decision,No,,,,,EMEA/V/A/068,,,,,,,,08/06/2011,24/08/2011,03/02/2012,03/02/2012,https://www.ema.europa.eu/en/medicines/veterinary/referrals/clavudale-50mg-tablet-cats-dogs
Human,Dexamethasone Alapis,dexamethasone,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1308,,,,,,,,21/07/2011,24/10/2011,23/07/2011,02/02/2012,https://www.ema.europa.eu/en/medicines/human/referrals/dexamethasone-alapis
Human,Diflucan,fluconazole,European Commission final decision,No,Article 30 referrals,,Fluconazole  ;Fungustatin  ;Fungata  ;Triflucan,,EMEA/H/A-30/1156,,,,,,,,23/06/2011,02/09/2011,24/06/2011,02/02/2012,https://www.ema.europa.eu/en/medicines/human/referrals/diflucan
Veterinary,Cephalosporins,ceftiofur;cefquinome,European Commission final decision,No,,,,,EMEA/V/A/070,,,,,,,,13/10/2011,13/01/2012,01/02/2012,01/02/2012,https://www.ema.europa.eu/en/medicines/veterinary/referrals/cephalosporins
Human,Levothyroxine Alapis,levothyroxine sodium,European Commission final decision,No,Article 29(4) referrals,,,-,EMEA/H/A-29/1328,,,,,,,,18/10/2012,14/01/2013,19/01/2012,19/01/2012,https://www.ema.europa.eu/en/medicines/human/referrals/levothyroxine-alapis
Human,Protium,pantoprazole,European Commission final decision,No,Article 30 referrals,,Anagastra  ;Apton  ;Controloc  ;Eupantol  ;Inipomp  ;Pantec  ;Pantecta  ;Pantipp  ;Panto-Byk-20 / 40 / IV  ;Pantoc  ;Pantoloc  ;PantoLomberg  ;Pantopan  ;Pantorc  ;Pantozol  ;Peptazol  ;Rifun  ;Somac  ;Ulcotenal  ;Zurcal  ;Zurcale  ;Zurcazol,,EMEA/H/A-30/1002,,,,,,,,17/12/2009,15/04/2010,17/12/2009,17/01/2012,https://www.ema.europa.eu/en/medicines/human/referrals/protium
Human,Dexrazoxane,dexrazoxane,European Commission final decision,Yes,Article 31 referrals,,Cardioxane  ;Cyrdanax  ;Dexrazoxane Cyathus  ;Enaxozar  ;Procard,,EMEA/H/A-31/1275,,,,,,,,23/06/2011,13/09/2011,24/06/2011,16/01/2012,https://www.ema.europa.eu/en/medicines/human/referrals/dexrazoxane
Human,Cozaar,irbesartan,European Commission final decision,No,Article 29 paediatrics,,Loortan  ;Loortan Cardio Start  ;Cozaar Startpakkle  ;Cardopal Start  ;Lorzaar  ;Lorzaar start  ;Lorzaar Protect  ;Pinzaar  ;Lorzaar Varipharmstart  ;Lortaan  ;Neo-Lotan  ;Losaprex  ;Cozaar IC  ;Lortaar IC,,EMEA/H/A-29 PAD/1022,,,,,,,,23/10/2008,22/01/2009,13/01/2012,13/01/2012,https://www.ema.europa.eu/en/medicines/human/referrals/cozaar-0
Veterinary,Hiprabovis Pneumos,"Mannheimia haemolytica biotype A serotype A1, inactivated cell free suspension containing leukotoxoid Ph. Eur.;inactivated Histophilus somni Bailie strain",European Commission final decision,No,,,,-,EMEA/V/A/072,,,,,,,,14/07/2011,03/11/2011,09/12/2011,12/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/hiprabovis-pneumos
Veterinary,Combimox Lactating Cow,amoxicillin;clavulanic acid;Prednisolone,European Commission final decision,No,,,,,EMA/V/A/061,,,,,,,,06/04/2011,05/08/2011,08/12/2011,09/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/combimox-lactating-cow
Veterinary,APPM Respipharm,"formaldehyde-inactivated whole-cell bacterial vaccine containing three strains of Actinobacillus pleuropneumoniae (serotypes 2, 9 and 11) and one strain of Pasteurella multocida (serotype A)",European Commission final decision,No,,,,,EMA/839689/2009,,,,,,,,11/11/2009,27/01/2010,19/02/2010,08/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/appm-respipharm
Veterinary,Nisamox Lactating Cow,amoxicillin;clavulanic acid;Prednisolone,European Commission final decision,No,,,,,EMA/V/A/062,,,,,,,,06/04/2011,05/08/2011,08/12/2011,08/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/nisamox-lactating-cow
Veterinary,Combisyn Lactating Cow,amoxicillin;clavulanic acid;Prednisolone,European Commission final decision,No,,,,,EMA/V/A/063,,,,,,,,06/04/2011,05/08/2011,08/12/2011,08/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/combisyn-lactating-cow
Veterinary,Unisol,enrofloxacin,European Commission final decision,No,,,,,EMEA/215198/2009,,,,,,,,15/01/2009,05/05/2009,29/07/2009,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/unisol
Veterinary,Solacyl,,European Commission final decision,No,,,,,CVMP/209536/08,,,,,,,,13/02/2008,17/04/2008,23/05/2008,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/solacyl
Veterinary,Shotaflor,florfenicol,European Commission final decision,No,,,,,EMEA/313852/2009,,,,,,,,14/05/2009,03/08/2009,02/10/2009,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/shotaflor
Veterinary,Fenflor,florfenicol,European Commission final decision,No,,,,,EMEA/313849/2009,,,,,,,,14/05/2009,03/08/2009,02/10/2009,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/fenflor
Veterinary,Enro-K,enrofloxacin,European Commission final decision,No,,,,,EMEA/214378/2009,,,,,,,,15/01/2009,05/05/2009,29/07/2009,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/enro-k
Veterinary,Enurace 50,ephedrine,European Commission final decision,No,,,,,CVMP/532222/07,,,,,,,,18/04/2007,10/07/2007,15/11/2007,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/enurace-50
Veterinary,Ecomectin 18.7mg/g Oral Paste for Horses,ivermectin,European Commission final decision,No,,,,,CVMP/495339/07,,,,,,,,08/11/2007,17/01/2008,20/02/2008,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/ecomectin-187mg-g-oral-paste-horses
Veterinary,Equimectin,,European Commission final decision,No,,,,,CVMP/532271/07,,,,,,,,17/01/2007,02/04/2007,15/11/2007,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/equimectin
Veterinary,Equibactin vet.,trimethoprim;sulfadiazine,European Commission final decision,No,,,,,CVMP/455918/08,,,,,,,,12/12/2007,03/03/2008,09/10/2008,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/equibactin-vet
Veterinary,Doxyprex 100mg Premix,Doxycycline,European Commission final decision,No,,,,,CVMP/532206/07,,,,,,,,14/02/2007,22/05/2007,15/11/2007,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/doxyprex-100mg-premix
Veterinary,Compagel,heparin sodium;levomenthol;hydroxyethyl salicylate,European Commission final decision,No,,,,,CVMP/459391/08,,,,,,,,13/02/2008,02/04/2008,09/10/2008,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/compagel
Veterinary,Bovilis BVD,,European Commission final decision,No,,,,,CVMP532090/07,,,,,,,,17/04/2007,29/06/2007,15/11/2007,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/bovilis-bvd
Veterinary,Dolovet Rifen,ketoprofen,European Commission final decision,No,,,,,CVMP/532160/07,,,,,,,,09/11/2006,17/04/2007,15/11/2007,07/12/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/dolovet-rifen
Veterinary,Synulox Lactating Cow,Amoxicillin trihydrate;potassium clavulanate;Prednisolone,European Commission final decision,No,,,,,EMA/512798/2011,,,,,,,,07/06/2011,20/10/2011,17/11/2011,17/11/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/synulox-lactating-cow
Human,Bufexamac,bufexamac,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Parfenac  ;Bufal  ;Calmaderm  ;Fansamac  ;Mastu S  ;Parfenoide  ;Proctosan,,EMEA/H/A-107/001260,,,,,,,,22/04/2010,27/07/2010,22/04/2010,10/11/2011,https://www.ema.europa.eu/en/medicines/human/referrals/bufexamac
Human,Vascace Plus,cilazapril;hydrochlorothiazide,European Commission final decision,No,Article 30 referrals,,Co-Inhibace  ;Dynorm Plus  ;Inhibace Plus,,EMEA/H/A-30/001153,,,,,,,,21/10/2010,21/01/2011,22/10/2010,09/11/2011,https://www.ema.europa.eu/en/medicines/human/referrals/vascace-plus
Human,Ketoprofen topical,ketoprofen,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Fastum  ;Ketum  ;Orudis,,EMEA/H/A-107/001259,,,,,,,,22/07/2010,29/11/2010,22/07/2010,28/10/2011,https://www.ema.europa.eu/en/medicines/human/referrals/ketoprofen-topical
Human,Bisphosphonates,alendronic acid;clodronic acid;etidronic acid;ibandronic acid;neridronic acid;pamidronic acid;risedronic acid;tiludronic acid;zoledronic acid,European Commission final decision,Yes,Article 31 referrals,,Actonel  ;Aredia  ;Bonefos  ;Didronel  ;Fosamax  ;Nerixia  ;Skelid,Bisphosphonates,EMA/288359/2011,,,,,,,,14/04/2011,13/07/2011,15/04/2011,28/10/2011,https://www.ema.europa.eu/en/medicines/human/referrals/bisphosphonates
Human,Atacand Plus,candesartan;hydrochlorothiazide,European Commission final decision,No,Article 30 referrals,,Atacand Zid  ;Blopresid  ;Blopress Comp  ;Blopress Plus  ;CoKenzen  ;Hytacand  ;Parapres Plus  ;Ratacand Plus,,EMEA/H/A-30/001152,,,,,,,,24/06/2010,16/09/2010,25/06/2010,21/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/atacand-plus
Human,Prevora,chlorhexidine diacetate,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1258,,,,,,,,23/09/2010,03/12/2010,24/09/2010,20/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/prevora
Human,Losec,omeprazole,European Commission final decision,No,Article 30 referrals,,Antra  ;Logastric  ;Losec Forte  ;Mopral  ;Omeprazen  ;Omeprazole  ;AstraZeneca  ;Zoltum,,EMEA/H/A-30/1001,,,,,,,,20/01/2010,10/06/2010,22/01/2010,19/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/losec
Human,Norsed Combi D,risedronate sodium;Calcium carbonate;colecalciferol,European Commission final decision,No,Article 29(4) referrals,,Actonel Combi D  ;Optinate Plus Ca&D  ;Opticalcio D3,,EMEA/H/A-29/001273,,,,,,,,24/06/2010,05/10/2010,25/06/2010,13/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/norsed-combi-d
Human,Fortipan Combi D,risedronate sodium;Calcium carbonate;colecalciferol,European Commission final decision,No,Article 29(4) referrals,,Actocalcio D3  ;Acrelcombi,,EMEA/H/A-29/001272,,,,,,,,24/06/2010,05/10/2010,25/06/2010,13/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/fortipan-combi-d
Human,Lescol,fluvastatin,European Commission final decision,No,Article 30 referrals,,Canef  ;Cardiol  ;Cardiol XL  ;Cranoc  ;Digardil  ;Digaril Prolib  ;Fluvastatin Novartis  ;Fluvastatina  ;Fractal  ;Leposit Prolib  ;Lescol Depot  ;Lescol Exel  ;Lescol LP  ;Lescol MR  ;Lescol Prolib  ;Lescol XL  ;Lipaxan  ;Lipaxin  ;Liposit  ;Locol  ;Lymetel  ;Primesin  ;Vaditon  ;Vaditon Prolib,,EMEA/H/A-30/1078,,,,,,,,19/11/2009,15/03/2010,20/11/2009,13/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/lescol
Human,Kytril,granisetron,European Commission final decision,No,Article 30 referrals,,Kevatril,,EMEA/H/A-30/1155,,,,,,,,19/05/2011,20/07/2011,20/05/2011,12/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/kytril
Human,Famvir,famciclovir,European Commission final decision,No,Article 30 referrals,,Famciclovir-Sandoz  ;Famciclovir-SB  ;Famciclovir-SB Zoster  ;Famvir Zoster and Oravir,,EMEA/H/A-30/001005,,,,,,,,22/04/2010,27/07/2010,23/04/2010,09/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/famvir
Human,Clopidogrel Teva,clopidogrel,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1246,,,,,,,,18/02/2010,04/06/2010,19/02/2010,08/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/clopidogrel-teva
Human,Clopidogrel Orion,clopidogrel,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1247,,,,,,,,18/02/2010,02/06/2010,19/02/2010,08/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/clopidogrel-orion
Human,Levact,bendamustine,European Commission final decision,No,Article 29(4) referrals,,Ribomustin,,EMEA/H/A-29/1238,,,,,,,,18/03/2010,07/07/2010,19/03/2010,08/09/2011,https://www.ema.europa.eu/en/medicines/human/referrals/levact
Veterinary,Doxyfar 50%,doxycycline hyclate,European Commission final decision,No,,,,,EMA/512470/2011,,,,,,,,04/05/2011,13/07/2011,23/08/2011,24/08/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/doxyfar-50
Veterinary,Doxycycline 50% WSP,doxycycline hyclate,European Commission final decision,No,,,,,EMA/507899/2011,,,,,,,,04/05/2011,13/07/2011,23/08/2011,24/08/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/doxycycline-50-wsp
Human,Benfluorex,benfluorex,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,,,EMA/811097/2009 Rev. 1,,,,,,,,18/03/2010,14/06/2010,18/12/2009,27/07/2011,https://www.ema.europa.eu/en/medicines/human/referrals/benfluorex
Human,Arimidex,anastrozole,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/001263,,,,,,,,17/03/2011,18/05/2011,18/03/2011,27/07/2011,https://www.ema.europa.eu/en/medicines/human/referrals/arimidex
Human,Isotretinoin,isotretinoin,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/001276,,,,,,,,16/12/2010,18/05/2011,17/12/2010,15/07/2011,https://www.ema.europa.eu/en/medicines/human/referrals/isotretinoin-0
Veterinary,Doxycycline hyclate,doxycycline hyclate,European Commission final decision,No,,,,,EMA/190025/2010,,,,,,,,11/02/2010,14/06/2010,16/07/2010,28/06/2011,https://www.ema.europa.eu/en/medicines/veterinary/referrals/doxycycline-hyclate
Human,Myderison,tolperisone hydrochloride,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/675340/2009,,,,,,,,22/10/2009,06/08/2010,23/10/2009,16/06/2011,https://www.ema.europa.eu/en/medicines/human/referrals/myderison
Human,Modified-released oral opioids,hydromorphone;morphine;oxycodone,European Commission final decision,Yes,Article 31 referrals,,,Opioids of the World Health Organization level III scale,EMEA/H/A-31/001232,,,,,,,,18/11/2010,20/04/2011,19/11/2010,06/06/2011,https://www.ema.europa.eu/en/medicines/human/referrals/modified-released-oral-opioids
Human,Iodocasein- and thiamine-containing medicinal products,iodocasein;thiamine nitrate,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Antiadiposo,,EMEA/H/A-107,,,,,,,,10/10/2009,,27/05/2011,27/05/2011,https://www.ema.europa.eu/en/medicines/human/referrals/iodocasein-thiamine-containing-medicinal-products
Human,Ethirfin,morphine sulphate,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/001248,,,,,,,,23/09/2010,20/12/2010,23/07/2010,29/04/2011,https://www.ema.europa.eu/en/medicines/human/referrals/ethirfin
Human,Valproate,valproic acid;valproate,European Commission final decision,Yes,Article 31 referrals,,,,"EMEA/H/A-31/1163, EMEA/H/A-6(12)/1147",,,,,,,,17/12/2009,26/08/2010,18/12/2009,29/04/2011,https://www.ema.europa.eu/en/medicines/human/referrals/valproate
Human,Sortis,atorvastatin,European Commission final decision,No,Article 29 paediatrics,,Lipitor  ;Zarator  ;Orbeos  ;Tahor  ;Liprimar  ;Atorvastatin  ;Atorvastatina  ;Edovin  ;Obradon  ;Xarator  ;Torvast  ;Totalip  ;Texzor  ;Cardyl  ;Prevencor,,EMEA/H/A-29 PAD/1255,,,,,,,,18/03/2010,01/07/2010,27/04/2011,27/04/2011,https://www.ema.europa.eu/en/medicines/human/referrals/sortis-2
Human,Sortis,atorvastatin,European Commission final decision,No,Article 29 paediatrics,,Lipitor  ;Zarator  ;Orbeos  ;Tahor  ;Liprimar  ;Atorvastatin  ;Atorvastatina  ;Edovin  ;Obradon  ;Xarator  ;Torvast  ;Totalip  ;Texzor  ;Cardyl  ;Prevencor,,EMEA/H/A-29 PAD/1254,,,,,,,,18/03/2010,01/07/2010,27/04/2011,27/04/2011,https://www.ema.europa.eu/en/medicines/human/referrals/sortis-0
Human,Sortis,atorvastatin,European Commission final decision,No,Article 29 paediatrics,,Lipitor  ;Zarator  ;Orbeos  ;Tahor  ;Liprimar  ;Atorvastatin  ;Atorvastatina  ;Edovin  ;Obradon  ;Xarator  ;Torvast  ;Totalip  ;Texzor  ;Cardyl  ;Prevencor,,EMEA/H/A-29 PAD/1253,,,,,,,,18/03/2010,01/07/2010,27/04/2011,27/04/2011,https://www.ema.europa.eu/en/medicines/human/referrals/sortis-1
Human,Modafinil,modafinil,European Commission final decision,Yes,Article 31 referrals,,Modasomil  ;Modiodal  ;Provigil  ;Vigil,,EMEA/H/A-31/1186,,,,,,,,18/11/2010,27/01/2011,19/11/2010,26/04/2011,https://www.ema.europa.eu/en/medicines/human/referrals/modafinil
Human,Daivobet,calcipotriol;betamethasone,European Commission final decision,No,Article 30 referrals,,Dovobet,,EMEA/H/A-30/001266,,,,,,,,22/07/2010,30/09/2010,23/07/2010,26/04/2011,https://www.ema.europa.eu/en/medicines/human/referrals/daivobet
Human,Genotropin,somatropin,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,Genotonorm,,EMEA/H/C/A-6(12)/001251,,,,,,,,24/06/2010,02/09/2010,25/06/2010,26/04/2011,https://www.ema.europa.eu/en/medicines/human/referrals/genotropin-0
Human,Octagam,human normal immunoglobulin,European Commission final decision,Yes,Article 31 referrals,,,,EMEA/H/A-31/001281,,,,,,,,14/04/2011,30/05/2011,14/04/2011,26/04/2011,https://www.ema.europa.eu/en/medicines/human/referrals/octagam
Human,Dextropropoxyphene,dextropropoxyphene,European Commission final decision,Yes,Article 31 referrals,,,,CHMP/681374/2009,,,,,,,,22/10/2009,14/06/2010,22/10/2009,07/04/2011,https://www.ema.europa.eu/en/medicines/human/referrals/dextropropoxyphene
Human,Atacand,candesartan,European Commission final decision,No,Article 30 referrals,,Amias  ;Blopress  ;Kenzen  ;Racanda  ;Ratacand  ;Parapres,,EMEA/H/A-30/001150,,,,,,,,18/03/2010,13/07/2010,19/03/2010,16/03/2011,https://www.ema.europa.eu/en/medicines/human/referrals/atacand
Human,Pantoprazole Bluefish,pantoprazole,European Commission final decision,No,Article 29(4) referrals,,Pantecta,,EMEA/H/A-29/1216,,,,,,,,19/11/2009,30/03/2010,20/11/2009,09/03/2011,https://www.ema.europa.eu/en/medicines/human/referrals/pantoprazole-bluefish
Human,Sibutramine,sibutramine,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,,-,"EMA/808179/2009, EMA/H/A-107/1256",,,,,,,,21/01/2010,06/08/2010,21/01/2010,09/03/2011,https://www.ema.europa.eu/en/medicines/human/referrals/sibutramine
Human,Pantoprazole Olinka (EMEA/H/A-29/1170),pantoprazole,European Commission final decision,No,Article 29(4) referrals,,Pantecta,,EMEA/H/A-29/1170,,,,,,,,19/11/2009,30/03/2010,20/11/2009,08/03/2011,https://www.ema.europa.eu/en/medicines/human/referrals/pantoprazole-olinka-emea-h-29-1170
Human,Pantoprazole Olinka (EMEA/H/A-29/1169),pantoprazole,European Commission final decision,No,Article 29(4) referrals,,Pantecta,,EMEA/H/A-29/1169,,,,,,,,19/11/2009,30/03/2010,20/11/2009,08/03/2011,https://www.ema.europa.eu/en/medicines/human/referrals/pantoprazole-olinka-emea-h-29-1169
Veterinary,Tildren,tiludronic acid,European Commission final decision,No,,,,,EMA/193771/2010,,,,,,,,22/07/2010,22/07/2013,14/12/2010,14/12/2010,https://www.ema.europa.eu/en/medicines/veterinary/referrals/tildren
Human,Xalatan,latanoprost,European Commission final decision,No,Article 29 paediatrics,,"Latanoprost Pharmacia & Upjohn  ;Xalatan 50 mikrogramov/ml kaplijice za oko, raztopina",,EMEA/H/A-29 PAE/1270,,,,,,,,22/07/2010,15/10/2010,08/12/2010,08/12/2010,https://www.ema.europa.eu/en/medicines/human/referrals/xalatan
Human,Gadolinium-containing contrast agents,gadodiamide;gadopentetic acid;gadobenic acid;gadoxetic acid;gadoteridol;gadobutrol;gadoteric acid,European Commission final decision,Yes,Article 31 referrals,,Omniscan  ;Magnevist  ;Magnegita  ;Gado-MRT ratiopharm  ;Primovist  ;MultiHance  ;Dotarem  ;ProHance  ;Gadovist,,EMEA/H/A-31/1097,,,,,,,,18/03/2010,01/07/2010,20/11/2009,06/12/2010,https://www.ema.europa.eu/en/medicines/human/referrals/gadolinium-containing-contrast-agents-0
Human,Seroquel XR,quetiapine,European Commission final decision,No,Article 6(13) referrals (prior to January 2010),,,,EMEA/H/6(13)/001188,,,,,,,,22/04/2010,26/08/2010,23/04/2010,19/11/2010,https://www.ema.europa.eu/en/medicines/human/referrals/seroquel-xr
Veterinary,Pregsure BVD,"inactivated Bovine Viral Diarrhoea (BVD) type 1 virus, cytopathogenic strain 5960",European Commission final decision,No,,,,-,EMA/434219/2010,,,,,,,,15/07/2010,07/10/2010,26/08/2010,22/10/2010,https://www.ema.europa.eu/en/medicines/veterinary/referrals/pregsure-bvd
Human,Fortum,ceftazidime,European Commission final decision,No,Article 30 referrals,,Cefortam  ;Glazidim  ;Panzim  ;Solvetan,,EMEA/H/A-30/001006,,,,,,,,21/10/2010,13/01/2011,22/10/2010,22/10/2010,https://www.ema.europa.eu/en/medicines/human/referrals/fortum
Human,Vascace,cilazapril,European Commission final decision,No,Article 30 referrals,,Dynorm  ;Inhibace  ;Inibace  ;Justor,,EMEA/H/A-30/001151,,,,,,,,22/04/2010,07/07/2010,23/04/2010,19/10/2010,https://www.ema.europa.eu/en/medicines/human/referrals/vascace
Veterinary,Poulvac Bursa Plus,"live infectious bursal disease virus, strain V877",European Commission final decision,No,,,,,EMA/698942/2009,,,,,,,,25/01/2010,25/01/2010,07/10/2010,07/10/2010,https://www.ema.europa.eu/en/medicines/veterinary/referrals/poulvac-bursa-plus
Human,Escitalopram,escitalopram,CHMP opinion,No,Article 30 referrals,,,,EMEA/H/A-30/1231,,,,,,,,18/02/2010,,19/02/2010,29/09/2010,https://www.ema.europa.eu/en/medicines/human/referrals/escitalopram
Human,Methylphenidate,methylphenidate,European Commission final decision,Yes,Article 31 referrals,,,,EMEA/658285/2008,,,,,,,,22/01/2009,27/05/2009,22/01/2009,22/09/2010,https://www.ema.europa.eu/en/medicines/human/referrals/methylphenidate
Veterinary,Porcilis M Hyo,inactivated whole cell concentrate of Mycoplasma hyopneumoniae strain 11,European Commission final decision,No,,,,-,EMA/345914/2010,,,,,,,,19/05/2010,16/08/2010,18/08/2010,18/08/2010,https://www.ema.europa.eu/en/medicines/veterinary/referrals/porcilis-m-hyo
Veterinary,Porcilis PRRS,live attenuated PRRS virus strain DV,European Commission final decision,No,,,,-,EMA/344861/2010,,,,,,,,19/05/2010,16/08/2010,18/08/2010,18/08/2010,https://www.ema.europa.eu/en/medicines/veterinary/referrals/porcilis-prrs
Veterinary,Tiamutin,tiamulin hydrogen fumarate,European Commission final decision,No,,,,,V-A-042,,,,,,,,10/03/2010,27/07/2010,21/07/2010,30/07/2010,https://www.ema.europa.eu/en/medicines/veterinary/referrals/tiamutin
Human,Teicoplanin Hospira,teicoplanin,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1084,,,,,,,,22/10/2009,29/01/2010,23/10/2009,27/07/2010,https://www.ema.europa.eu/en/medicines/human/referrals/teicoplanin-hospira
Veterinary,Quinolones,enrofloxacin;marbofloxacin;danofloxacin mesilate;danofloxacin;flumequine;amoxicillin;difloxacin hydrochloride;oxolinic acid;Colistin sulfate;Amoxicillin trihydrate;difloxacin;bromhexine;oxytetracycline hydrochloride,European Commission final decision,No,,,,,EMA/186029/2010,,,,,,,,09/03/2010,01/07/2010,16/07/2010,16/07/2010,https://www.ema.europa.eu/en/medicines/veterinary/referrals/quinolones
Veterinary,Colistin,Colistin sulfate,European Commission final decision,No,,,,,EMA/189829/2010,,,,,,,,10/02/2010,10/06/2010,24/06/2010,24/06/2010,https://www.ema.europa.eu/en/medicines/veterinary/referrals/colistin
Human,Diovan,valsartan,European Commission final decision,No,Article 29 paediatrics,,Angiosan  ;Diovane  ;Tareg  ;Cordinate  ;Provas  ;Dalzad  ;Rixil  ;Kalpress Cardio  ;Diovan Cardio  ;Miten Cardio  ;Valsartan Novartis  ;Kalpress  ;Miten,,EMEA/H/A/-29 PAD/1220,,,,,,,,15/12/2009,19/04/2010,31/05/2010,31/05/2010,https://www.ema.europa.eu/en/medicines/human/referrals/diovan
Human,Diovan,valsartan,European Commission final decision,No,Article 29 paediatrics,,Angiosan  ;Diovane  ;Tareg  ;Cordinate  ;Provas  ;Dalzad  ;Rixil  ;Kalpress Cardio  ;Diovan Cardio  ;Miten Cardio  ;Valsartan Novartis,,EMEA/H/A-29 PAD/1219,,,,,,,,15/12/2009,19/04/2010,31/05/2010,31/05/2010,https://www.ema.europa.eu/en/medicines/human/referrals/diovan-1
Human,Arimidex,anastrozole,European Commission final decision,No,Article 29 paediatrics,,,,EMA/311974/2010,,,,,,,,,06/11/2009,28/05/2010,28/05/2010,https://www.ema.europa.eu/en/medicines/human/referrals/arimidex-0
Veterinary,Cevazuril,toltrazuril,European Commission final decision,No,,,,,EMA/214243/2009,,,,,,,,09/12/2009,26/03/2010,05/05/2010,05/05/2010,https://www.ema.europa.eu/en/medicines/veterinary/referrals/cevazuril
Veterinary,Pharmasin,tylosin tartrate,European Commission final decision,No,,,,macrolide antibiotic,EMA/214243/2009,,,,,,,,12/03/2009,08/01/2010,30/04/2010,30/04/2010,https://www.ema.europa.eu/en/medicines/veterinary/referrals/pharmasin
Veterinary,Pulmotil AC,tilmicosin,European Commission final decision,No,,,,,EMEA/608943/2009,,,,,,,,16/07/2009,15/10/2010,22/12/2009,22/12/2009,https://www.ema.europa.eu/en/medicines/veterinary/referrals/pulmotil-ac
Veterinary,Pulmotil Premix,tilmicosin,European Commission final decision,No,,,,,EMEA/608931/2009,,,,,,,,16/07/2009,15/10/2009,22/12/2009,22/12/2009,https://www.ema.europa.eu/en/medicines/veterinary/referrals/pulmotil-premix
Human,Topamax,topiramate,European Commission final decision,No,Article 30 referrals,,,,CHMP/239500/2009,,,,,,,,25/06/2009,01/10/2009,15/12/2009,15/12/2009,https://www.ema.europa.eu/en/medicines/human/referrals/topamax
Human,Loratadine Sandoz 10,loratadine,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1060,,,,,,,,29/05/2009,06/08/2009,12/12/2009,12/12/2009,https://www.ema.europa.eu/en/medicines/human/referrals/loratadine-sandoz-10
Human,Meronem,meropenem,European Commission final decision,No,Article 30 referrals,,,,EMEA/H/A-30/1003,,,,,,,,23/07/2009,15/10/2009,12/12/2009,12/12/2009,https://www.ema.europa.eu/en/medicines/human/referrals/meronem
Human,Extraneal,icodextrin,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CHMP/683039/2009,,,,,,,,22/10/2009,20/01/2010,27/10/2009,27/10/2009,https://www.ema.europa.eu/en/medicines/human/referrals/extraneal
Veterinary,Ivermectin,ivermectin,European Commission final decision,No,,,,,EMEA/471056/2009,,,,,,,,05/06/2009,01/10/2009,26/10/2009,26/10/2009,https://www.ema.europa.eu/en/medicines/veterinary/referrals/ivermectin
Human,Rapinyl,fentanyl citrate,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/336144/08,,,,,,,,26/06/2008,11/09/2008,25/09/2009,25/09/2009,https://www.ema.europa.eu/en/medicines/human/referrals/rapinyl
Human,Prokanazol,itraconazole,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/454809/2009,,,,,,,,23/04/2009,14/07/2009,06/08/2009,06/08/2009,https://www.ema.europa.eu/en/medicines/human/referrals/prokanazol
Human,Octegra,moxifloxacin,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/150525/2009,,,,,,,,19/03/2009,02/10/2009,25/06/2009,25/06/2009,https://www.ema.europa.eu/en/medicines/human/referrals/octegra
Human,Budesonide Sandoz,budesonide,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1062,,,,,,,,20/02/2009,07/05/2009,25/06/2009,25/06/2009,https://www.ema.europa.eu/en/medicines/human/referrals/budesonide-sandoz
Human,Fentrix,fentanyl,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/393579/2009,,,,,,,,25/06/2009,06/10/2009,25/06/2009,25/06/2009,https://www.ema.europa.eu/en/medicines/human/referrals/fentrix
Human,Gluscan 500,fludeoxyglucose (18F),European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1123,,,,,,,,20/03/2009,29/05/2009,23/06/2009,23/06/2009,https://www.ema.europa.eu/en/medicines/human/referrals/gluscan-500
Veterinary,Alpha2-adrenoreceptor agonists,Xylazine;medetomidine;detomidine;romifidine,European Commission final decision,No,,,,-,EMEA/681319/2008,,,,,,,,12/11/2008,30/04/2009,22/06/2009,22/06/2009,https://www.ema.europa.eu/en/medicines/veterinary/referrals/alpha2-adrenoreceptor-agonists
Human,Diovan Comp,valsartan;hydrochlorothiazide,European Commission final decision,No,Article 30 referrals,,,,CHMP/113861/2009,,,,,,,,19/03/2009,26/05/2009,11/06/2009,11/06/2009,https://www.ema.europa.eu/en/medicines/human/referrals/diovan-comp
Human,Zoloft,sertraline,European Commission final decision,No,Article 30 referrals,,,,CHMP/634674/08,,,,,,,,18/12/2008,27/03/2009,07/05/2009,07/05/2009,https://www.ema.europa.eu/en/medicines/human/referrals/zoloft
Human,Tritace,ramipril,European Commission final decision,No,Article 30 referrals,,,,CHMP/233264/2009,,,,,,,,18/12/2008,06/03/2009,24/04/2009,24/04/2009,https://www.ema.europa.eu/en/medicines/human/referrals/tritace
Human,Tritazide,ramipril;hydrochlorothiazide,European Commission final decision,No,Article 30 referrals,,,,CHMP/204584/2009,,,,,,,,18/12/2008,06/03/2009,14/04/2009,14/04/2009,https://www.ema.europa.eu/en/medicines/human/referrals/tritazide
Human,Bleomycin,bleomycin,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/173797/2009,,,,,,,,19/12/2008,12/03/2009,31/03/2009,31/03/2009,https://www.ema.europa.eu/en/medicines/human/referrals/bleomycin
Human,Sanohex,salbutamol,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/194790/2009,,,,,,,,19/12/2008,12/03/2009,30/03/2009,30/03/2009,https://www.ema.europa.eu/en/medicines/human/referrals/sanohex
Human,Sabumalin,salbutamol,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/194784/2009,,,,,,,,19/12/2008,12/03/2009,30/03/2009,30/03/2009,https://www.ema.europa.eu/en/medicines/human/referrals/sabumalin
Human,Uman Big,human hepatitis B immunoglobulin,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/173455/2009,,,,,,,,19/12/2008,06/03/2009,21/03/2009,21/03/2009,https://www.ema.europa.eu/en/medicines/human/referrals/uman-big
Human,Diovan,valsartan,European Commission final decision,No,Article 30 referrals,,,,CHMP/137577/2009,,,,,,,,21/11/2008,16/02/2009,13/03/2009,13/03/2009,https://www.ema.europa.eu/en/medicines/human/referrals/diovan-0
Human,Implanon,etonogestrel,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/85200/2009,,,,,,,,21/11/2008,06/02/2009,27/02/2009,27/02/2009,https://www.ema.europa.eu/en/medicines/human/referrals/implanon
Human,Trimetadizine ratiopharm,trimetazidine,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/45404/2009,,,,,,,,22/01/2009,19/03/2009,22/01/2009,22/01/2009,https://www.ema.europa.eu/en/medicines/human/referrals/trimetadizine-ratiopharm
Human,Mephatrim,trimetazidine,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/45405/2009,,,,,,,,22/01/2009,19/03/2009,22/01/2009,22/01/2009,https://www.ema.europa.eu/en/medicines/human/referrals/mephatrim
Human,Efexor depot,venlafaxine,European Commission final decision,No,Article 30 referrals,,,,CHMP/384876/2008,,,,,,,,24/07/2008,28/11/2008,20/12/2008,20/12/2008,https://www.ema.europa.eu/en/medicines/human/referrals/efexor-depot
Human,Lisonorm,lisinopril;amlodipine,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/633842/2008,,,,,,,,25/07/2008,12/11/2008,18/12/2008,18/12/2008,https://www.ema.europa.eu/en/medicines/human/referrals/lisonorm
Human,Efexor,venlafaxine,European Commission final decision,No,Article 30 referrals,,,,CHMP/384875/2008,,,,,,,,24/07/2008,28/11/2008,18/12/2008,18/12/2008,https://www.ema.europa.eu/en/medicines/human/referrals/efexor
Human,Arcoxia,etoricoxib,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CHMP/438258/08,,,,,,,,26/06/2008,09/09/2008,21/11/2008,21/11/2008,https://www.ema.europa.eu/en/medicines/human/referrals/arcoxia
Human,Etoricoxib,etoricoxib,European Commission final decision,Yes,Article 31 referrals,,,,"EMEA/329177/2008, CHMP/542169/08",,,,,,,,26/06/2008,,21/11/2008,21/11/2008,https://www.ema.europa.eu/en/medicines/human/referrals/etoricoxib
Veterinary,Sodium Salicylate,sodium salicylate,European Commission final decision,No,,,,,EMEA/436209/2008,,,,,,,,16/07/2008,26/09/2008,19/11/2008,19/11/2008,https://www.ema.europa.eu/en/medicines/veterinary/referrals/sodium-salicylate
Human,Risperdal,risperidone,European Commission final decision,No,Article 30 referrals,,,,CHMP/384877/2008,,,,,,,,24/07/2008,07/10/2008,13/11/2008,13/11/2008,https://www.ema.europa.eu/en/medicines/human/referrals/risperdal
Human,Ciprofloxacin Bayer,ciprofloxacin,European Commission final decision,No,Article 30 referrals,,,,CHMP/384874/08,,,,,,,,24/07/2008,07/10/2008,23/10/2008,23/10/2008,https://www.ema.europa.eu/en/medicines/human/referrals/ciprofloxacin-bayer
Human,Risperdal Consta,risperidone,European Commission final decision,No,Article 30 referrals,,,,CHMP/384879/08,,,,,,,,24/07/2008,07/10/2008,22/10/2008,22/10/2008,https://www.ema.europa.eu/en/medicines/human/referrals/risperdal-consta
Human,Zyrtec,cetirizine,European Commission final decision,No,Article 30 referrals,,,,CHMP/296484/08,,,,,,,,30/05/2008,06/10/2008,16/10/2008,16/10/2008,https://www.ema.europa.eu/en/medicines/human/referrals/zyrtec
Veterinary,Suramox 15 % LA and its associated name Stabox 15 % LA,amoxicillin,European Commission final decision,No,,,,,CVMP/344321/08,,,,,,,,18/06/2008,05/09/2008,15/10/2008,15/10/2008,https://www.ema.europa.eu/en/medicines/veterinary/referrals/suramox-15-la-its-associated-name-stabox-15-la
Human,Avelox,moxifloxacin,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CHMP/524251/08,,,,,,,,20/03/2008,14/07/2008,13/10/2008,13/10/2008,https://www.ema.europa.eu/en/medicines/human/referrals/avelox
Human,Octegra,moxifloxacin,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CHMP/524284/08,,,,,,,,20/03/2008,14/07/2008,13/10/2008,13/10/2008,https://www.ema.europa.eu/en/medicines/human/referrals/octegra-0
Human,Actira,moxifloxacin,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CHMP/524135/08,,,,,,,,20/03/2008,14/07/2008,13/10/2008,13/10/2008,https://www.ema.europa.eu/en/medicines/human/referrals/actira
Human,Remeron,mirtazapine,European Commission final decision,No,Article 30 referrals,,,,CHMP/336158/08,,,,,,,,26/06/2008,15/09/2008,13/10/2008,13/10/2008,https://www.ema.europa.eu/en/medicines/human/referrals/remeron
Veterinary,Tribrissen,trimethoprim;sulfadiazine,European Commission final decision,No,,,,-,CVMP/457286/08,,,,,,,,12/12/2007,11/03/2008,09/10/2008,09/10/2008,https://www.ema.europa.eu/en/medicines/veterinary/referrals/tribrissen
Veterinary,Methoxasol-T,trimethoprim;sulfamethoxazole,European Commission final decision,No,,,,,CVMP/458933/08,,,,,,,,11/10/2007,11/01/2008,09/10/2008,09/10/2008,https://www.ema.europa.eu/en/medicines/veterinary/referrals/methoxasol-t
Human,Gemzar,gemcitabine,European Commission final decision,No,Article 30 referrals,,,,CHMP/512295/08,,,,,,,,26/06/2008,23/09/2008,06/10/2008,06/10/2008,https://www.ema.europa.eu/en/medicines/human/referrals/gemzar
Human,Activelle,estradiol;norethisterone acetate,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/336151/08,,,,,,,,26/06/2008,11/09/2008,25/09/2008,25/09/2008,https://www.ema.europa.eu/en/medicines/human/referrals/activelle
Human,Cozaar,losartan,European Commission final decision,No,Article 30 referrals,,,,CHMP/495795/07,,,,,,,,24/04/2008,03/09/2008,25/09/2008,25/09/2008,https://www.ema.europa.eu/en/medicines/human/referrals/cozaar
Human,Cozaar Comp,,European Commission final decision,No,Article 30 referrals,,,,CHMP/495840/07,,,,,,,,24/04/2008,03/09/2008,25/09/2008,25/09/2008,https://www.ema.europa.eu/en/medicines/human/referrals/cozaar-comp
Human,Lamictal,lamotrigine,European Commission final decision,No,Article 30 referrals,,,,CHMP/212114/08,,,,,,,,24/04/2008,23/07/2008,08/09/2008,08/09/2008,https://www.ema.europa.eu/en/medicines/human/referrals/lamictal
Human,Oracea,doxycycline monohydrate,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/428671/08,,,,,,,,24/04/2008,22/07/2008,21/08/2008,21/08/2008,https://www.ema.europa.eu/en/medicines/human/referrals/oracea
Human,Singulair,montelukast,European Commission final decision,No,Article 30 referrals,,,,CHMP/212107/08,,,,,,,,24/04/2008,11/07/2008,05/08/2008,05/08/2008,https://www.ema.europa.eu/en/medicines/human/referrals/singulair
Human,Alvesco,ciclesonide,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/151554/08,,,,,,,,20/03/2008,11/07/2008,05/08/2008,05/08/2008,https://www.ema.europa.eu/en/medicines/human/referrals/alvesco
Veterinary,Toltrazuril,toltrazuril,European Commission final decision,No,,,,-,EMEA/402698/2008,,,,,,,,16/07/2008,26/09/2008,26/07/2008,26/07/2008,https://www.ema.europa.eu/en/medicines/veterinary/referrals/toltrazuril
Human,Moxifloxacin,moxifloxacin,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Avalox  ;Avelox,,CHMP/380454/08,,,,,,,,24/07/2008,24/10/2008,24/07/2008,24/07/2008,https://www.ema.europa.eu/en/medicines/human/referrals/moxifloxacin
Human,Norfloxacin,norfloxacin,European Commission final decision,Yes,Article 31 referrals,,,,CHMP/262776/05,,,,,,,,24/07/2008,19/11/2008,29/08/2006,24/07/2008,https://www.ema.europa.eu/en/medicines/human/referrals/norfloxacin
Human,Belanette,drospirenone;ethinyl estradiol,European Commission final decision,No,Article 5(11) referrals (prior to January 2010),,,,CHMP/332403/08,,,,,,,,14/12/2007,17/06/2008,03/07/2008,03/07/2008,https://www.ema.europa.eu/en/medicines/human/referrals/belanette
Human,Yasminelle,drospirenone;ethinylestradiol,European Commission final decision,No,Article 5(11) referrals (prior to January 2010),,,,CHMP/40502/08,,,,,,,,14/12/2007,17/06/2008,03/07/2008,03/07/2008,https://www.ema.europa.eu/en/medicines/human/referrals/yasminelle
Human,Ergot-derived dopamine agonists,bromocriptine;cabergoline;dihydroergocryptine;lisuride;pergolide,European Commission final decision,Yes,Article 31 referrals,,,,CHMP/319054/08,,,,,,,,26/06/2008,,26/06/2008,26/06/2008,https://www.ema.europa.eu/en/medicines/human/referrals/ergot-derived-dopamine-agonists
Human,Menitorix,Haemophilus type b and Meningococcal group C conjugate vaccine,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/498198/07,,,,,,,,16/11/2007,01/04/2008,18/04/2008,18/04/2008,https://www.ema.europa.eu/en/medicines/human/referrals/menitorix
Human,Ciprofloxacin Nycomed,ciprofloxacin,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/350278/07,,,,,,,,17/11/2006,18/01/2008,18/02/2008,18/02/2008,https://www.ema.europa.eu/en/medicines/human/referrals/ciprofloxacin-nycomed
Human,Xeomin,clostridium botulinum neurotoxin type A,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/350251/07,,,,,,,,19/07/2007,24/10/2007,08/02/2008,08/02/2008,https://www.ema.europa.eu/en/medicines/human/referrals/xeomin
Human,Bicaluplex,bicalutamide,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/433691/07,,,,,,,,20/09/2007,22/11/2007,07/02/2008,07/02/2008,https://www.ema.europa.eu/en/medicines/human/referrals/bicaluplex
Human,Piroxicam,piroxicam,European Commission final decision,Yes,Article 31 referrals,,,,CHMP/380917/07,,,,,,,,21/06/2007,07/09/2007,31/01/2008,31/01/2008,https://www.ema.europa.eu/en/medicines/human/referrals/piroxicam
Human,Agreal,veralipride,European Commission final decision,Yes,Article 31 referrals,,,,CHMP/432352/07,,,,,,,,19/07/2007,01/10/2007,07/01/2008,07/01/2008,https://www.ema.europa.eu/en/medicines/human/referrals/agreal
Human,Fentanyl-ratiopharm TTS,fentanyl,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/331678/07,,,,,,,,19/07/2007,23/10/2007,14/12/2007,14/12/2007,https://www.ema.europa.eu/en/medicines/human/referrals/fentanyl-ratiopharm-tts
Human,Lansoprazole,Lansoprazole,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/283378/07,,,,,,,,21/06/2007,18/09/2007,14/12/2007,14/12/2007,https://www.ema.europa.eu/en/medicines/human/referrals/lansoprazole
Human,Fentanyl-ratiopharm Matrixpflaster,fentanyl,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/338591/07,,,,,,,,19/07/2007,23/10/2007,14/12/2007,14/12/2007,https://www.ema.europa.eu/en/medicines/human/referrals/fentanyl-ratiopharm-matrixpflaster
Human,Lumiracoxib,lumiracoxib,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Prexige,,EMEA/H/A-107,,,,,,,,13/12/2007,,14/12/2007,14/12/2007,https://www.ema.europa.eu/en/medicines/human/referrals/lumiracoxib
Human,Aprotinin,aprotinin,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Trasylol,,EMEA/533599/07,,,,,,,,15/11/2007,15/02/2008,22/11/2007,22/11/2007,https://www.ema.europa.eu/en/medicines/human/referrals/aprotinin
Human,Carisoprodol,carisoprodol,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Somadril,,CHMP/520140/07,,,,,,,,15/11/2007,05/02/2008,16/11/2007,16/11/2007,https://www.ema.europa.eu/en/medicines/human/referrals/carisoprodol
Veterinary,Suvaxyn Parvo/E,,European Commission final decision,No,,,,,CVMP/532267/07,,,,,,,,17/01/2007,17/04/2007,15/11/2007,15/11/2007,https://www.ema.europa.eu/en/medicines/veterinary/referrals/suvaxyn-parvo-e
Veterinary,Suvaxyn Ery,,European Commission final decision,No,,,,-,CVMP/532233/07,,,,,,,,17/01/2007,19/04/2007,15/11/2007,15/11/2007,https://www.ema.europa.eu/en/medicines/veterinary/referrals/suvaxyn-ery
Human,"Gadograf, Gadovist",gadobutrol,European Commission final decision,No,Article 36 referrals (prior to July 2012),,,,CHMP/508212/07,,,,,,,,17/11/2006,13/04/2007,09/11/2007,09/11/2007,https://www.ema.europa.eu/en/medicines/human/referrals/gadograf-gadovist
Human,Clobutinol,clobutinol,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Silomat,,CHMP/471052/07,,,,,,,,18/10/2007,30/11/2007,19/10/2007,19/10/2007,https://www.ema.europa.eu/en/medicines/human/referrals/clobutinol
Human,Bicalutamide 150 mg,bicalutamide,European Commission final decision,Yes,Article 31 referrals,,,,CHMP/378451/07,,,,,,,,24/05/2007,03/09/2007,03/10/2007,03/10/2007,https://www.ema.europa.eu/en/medicines/human/referrals/bicalutamide-150-mg
Human,Xefo,lornoxicam,European Commission final decision,No,Article 30 referrals,,,,CHMP/144030/07,,,,,,,,23/02/2007,29/05/2007,28/09/2007,28/09/2007,https://www.ema.europa.eu/en/medicines/human/referrals/xefo
Human,Cefuroximaxetil,cefuroxime (as axetil),European Commission final decision,No,Article 29(4) referrals,,,,CHMP/248862/07,,,,,,,,26/04/2007,22/08/2007,24/09/2007,24/09/2007,https://www.ema.europa.eu/en/medicines/human/referrals/cefuroximaxetil
Human,Nimesulide,nimesulide,European Commission final decision,Yes,Article 107 procedures (prior to July 2012),,Aulin  ;Nimed,,CHMP/430988/07,,,,,,,,20/09/2007,16/10/2009,21/09/2007,21/09/2007,https://www.ema.europa.eu/en/medicines/human/referrals/nimesulide
Human,Vantas,histrelin acetate,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/247760/07,,,,,,,,24/05/2007,30/07/2007,06/09/2007,06/09/2007,https://www.ema.europa.eu/en/medicines/human/referrals/vantas
Human,Ciprofloxacin Hikma,ciprofloxacin,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/75066/07,,,,,,,,25/01/2007,11/06/2007,06/09/2007,06/09/2007,https://www.ema.europa.eu/en/medicines/human/referrals/ciprofloxacin-hikma
Human,Alendronate HEXAL,alendronic acid (as sodium alendronate trihydrate),European Commission final decision,No,Article 29(4) referrals,,,,CHMP/75285/07,,,,,,,,25/01/2007,13/04/2007,20/08/2007,20/08/2007,https://www.ema.europa.eu/en/medicines/human/referrals/alendronate-hexal
Veterinary,Suramox,amoxicillin,European Commission final decision,No,,,,,CVMP/301122/07,,,,,,,,14/03/2007,13/06/2007,25/07/2007,25/07/2007,https://www.ema.europa.eu/en/medicines/veterinary/referrals/suramox
Human,Seretide Evohaler,salmeterol;fluticasone,European Commission final decision,No,Article 6(13) referrals (prior to January 2010),,,-,CHMP/306351/06,,,,,,,,27/04/2006,04/07/2006,14/07/2007,14/07/2007,https://www.ema.europa.eu/en/medicines/human/referrals/seretide-evohaler
Human,Viani Evohaler,salmeterol;fluticasone,European Commission final decision,No,Article 6(13) referrals (prior to January 2010),,,-,CHMP/306455/06,,,,,,,,27/04/2006,04/07/2006,14/07/2007,14/07/2007,https://www.ema.europa.eu/en/medicines/human/referrals/viani-evohaler
Human,Seretide Diskus,salmeterol;fluticasone,European Commission final decision,No,Article 6(13) referrals (prior to January 2010),,,-,CHMP/306065/06,,,,,,,,27/04/2006,04/07/2006,14/07/2007,14/07/2007,https://www.ema.europa.eu/en/medicines/human/referrals/seretide-diskus
Human,Betavert N,betahistine dihydrochloride,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/H/A-29/1094,,,,,,,,20/03/2009,02/06/2009,01/07/2007,01/07/2007,https://www.ema.europa.eu/en/medicines/human/referrals/betavert-n
Human,Ciprofloxacin Kabi,ciprofloxacin,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/515890/06,,,,,,,,17/11/2006,24/01/2007,06/02/2007,06/02/2007,https://www.ema.europa.eu/en/medicines/human/referrals/ciprofloxacin-kabi
Human,Agopton,Lansoprazole,European Commission final decision,No,Article 30 referrals,,,,CHMP/407636/06,,,,,,,,21/09/2006,13/12/2006,20/12/2006,20/12/2006,https://www.ema.europa.eu/en/medicines/human/referrals/agopton
Human,Glucomed,glucosamine hydrochloride,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/405628/06,,,,,,,,21/09/2006,13/12/2006,20/12/2006,20/12/2006,https://www.ema.europa.eu/en/medicines/human/referrals/glucomed
Human,Sortis,atorvastatin,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,-,CHMP/477258/06,,,,,,,,24/03/2006,22/05/2006,09/12/2006,09/12/2006,https://www.ema.europa.eu/en/medicines/human/referrals/sortis
Human,Doxagamma 4mg,Doxazosin,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/423308/06,,,,,,,,28/06/2006,11/10/2006,11/10/2006,11/10/2006,https://www.ema.europa.eu/en/medicines/human/referrals/doxagamma-4mg
Human,"Doxazosin ""Winthrop"" 4mg",Doxazosin,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/423591/06,,,,,,,,28/06/2006,11/10/2006,11/10/2006,11/10/2006,https://www.ema.europa.eu/en/medicines/human/referrals/doxazosin-winthrop-4mg
Human,Cardoreg 4mg,Doxazosin,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/422351/06,,,,,,,,28/06/2006,11/10/2006,11/10/2006,11/10/2006,https://www.ema.europa.eu/en/medicines/human/referrals/cardoreg-4mg
Human,"Doxazosin Retard ""Arrow"" 4 mg",Doxazosin,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/423796/06,,,,,,,,28/06/2006,11/10/2006,11/10/2006,11/10/2006,https://www.ema.europa.eu/en/medicines/human/referrals/doxazosin-retard-arrow-4-mg
Human,Doxastad 4 mg,Doxazosin,European Commission final decision,No,Article 29(4) referrals,,,-,CHMP/423384/06,,,,,,,,28/06/2006,11/10/2006,11/10/2006,11/10/2006,https://www.ema.europa.eu/en/medicines/human/referrals/doxastad-4-mg
Human,Neurontin,gabapentin,European Commission final decision,No,Article 30 referrals,,,,CHMP/142335/06,,,,,,,,01/06/2006,04/08/2006,06/09/2006,06/09/2006,https://www.ema.europa.eu/en/medicines/human/referrals/neurontin
Human,Prozac,fluoxetine,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CHMP/46089/06,,,,,,,,01/06/2006,21/08/2006,05/09/2006,05/09/2006,https://www.ema.europa.eu/en/medicines/human/referrals/prozac
Human,Ceftriaxone Tyrol Pharma,Ceftriaxone,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/212746/06,,,,,,,,01/06/2006,21/08/2006,30/08/2006,30/08/2006,https://www.ema.europa.eu/en/medicines/human/referrals/ceftriaxone-tyrol-pharma
Human,Elidel,pimecrolimus,European Commission final decision,Yes,Article 31 referrals,,,,"CHMP/80270/06, CHMP/262776/05",,,,,,,,23/03/2006,,29/08/2006,29/08/2006,https://www.ema.europa.eu/en/medicines/human/referrals/elidel
Human,Viani Diskus,salmeterol;fluticasone,European Commission final decision,No,Article 6(13) referrals (prior to January 2010),,,-,CHMP/306421/06,,,,,,,,27/04/2006,04/07/2006,14/07/2006,14/07/2006,https://www.ema.europa.eu/en/medicines/human/referrals/viani-diskus
Human,Stamaril,live attenuated yellow fever virus,European Commission final decision,No,Article 30 referrals,,,,CHMP/169383/06,,,,,,,,27/04/2006,04/07/2006,14/07/2006,14/07/2006,https://www.ema.europa.eu/en/medicines/human/referrals/stamaril
Human,Prograf,tacrolimus,European Commission final decision,No,Article 30 referrals,,,,CHMP/85997/06,,,,,,,,26/01/2006,10/04/2006,16/05/2006,16/05/2006,https://www.ema.europa.eu/en/medicines/human/referrals/prograf
Human,Nifedipine Pharmamatch 30 and 60 mg,nifedipine,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/106563/06,,,,,,,,27/01/2006,03/04/2006,05/05/2006,05/05/2006,https://www.ema.europa.eu/en/medicines/human/referrals/nifedipine-pharmamatch-30-60-mg
Human,Adartrel,ropinirole,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/CHMP/416317/2005,,,,,,,,15/09/2005,03/04/2006,21/04/2006,21/04/2006,https://www.ema.europa.eu/en/medicines/human/referrals/adartrel
Human,Lansoprazol CT-Arzneimittel 15 mg and 30 mg,Lansoprazole,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/373108/05,,,,,,,,15/09/2005,21/02/2006,25/02/2006,25/02/2006,https://www.ema.europa.eu/en/medicines/human/referrals/lansoprazol-ct-arzneimittel-15-mg-30-mg
Human,Lansoprazol-ratiopharm 15 mg and 30 mg,Lansoprazole,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/373061/05,,,,,,,,15/09/2005,21/02/2006,25/02/2006,25/02/2006,https://www.ema.europa.eu/en/medicines/human/referrals/lansoprazol-ratiopharm-15-mg-30-mg
Human,Lansoprazol AbZ-Pharma 15 mg and 30 mg,Lansoprazole,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/373083/05,,,,,,,,15/09/2005,21/02/2006,25/02/2006,25/02/2006,https://www.ema.europa.eu/en/medicines/human/referrals/lansoprazol-abz-pharma-15-mg-30-mg
Human,Actilyse,Alteplase,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/3346/02,,,,,,,,27/06/2002,30/09/2002,25/01/2006,25/01/2006,https://www.ema.europa.eu/en/medicines/human/referrals/actilyse
Human,Coversyl,perindopril,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,-,CHMP/408150/05,,,,,,,,27/07/2005,07/11/2005,23/12/2005,23/12/2005,https://www.ema.europa.eu/en/medicines/human/referrals/coversyl
Human,Celecoxib,celecoxib,European Commission final decision,Yes,Article 31 referrals,,,-,CHMP/323166/05,,,,,,,,23/06/2005,28/11/2005,06/12/2005,06/12/2005,https://www.ema.europa.eu/en/medicines/human/referrals/celecoxib
Human,Etoricoxib,etoricoxib,European Commission final decision,Yes,Article 31 referrals,,,-,CHMP/324317/05,,,,,,,,23/06/2005,28/11/2005,06/12/2005,06/12/2005,https://www.ema.europa.eu/en/medicines/human/referrals/etoricoxib-0
Human,Lumiracoxib,lumiracoxib,European Commission final decision,Yes,Article 31 referrals,,,,CHMP/324332/05,,,,,,,,23/06/2005,28/11/2005,06/12/2005,06/12/2005,https://www.ema.europa.eu/en/medicines/human/referrals/lumiracoxib-0
Human,Paroxetine,paroxetine,European Commission final decision,Yes,Article 31 referrals,,,,CHMP/187488/04,,,,,,,,09/12/2004,29/03/2005,22/11/2005,22/11/2005,https://www.ema.europa.eu/en/medicines/human/referrals/paroxetine
Human,Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors,atomoxetine;citalopram;escitalopram;fluoxetine;fluvoxamine;mianserine;milnacipran;mirtazapine;paroxetine;reboxetine;sertraline;venlafaxine,European Commission final decision,Yes,Article 31 referrals,,,Serotonin-specific reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors,CHMP/287837/05,,,,,,,,21/04/2005,19/08/2005,03/11/2005,03/11/2005,https://www.ema.europa.eu/en/medicines/human/referrals/serotonin-specific-reuptake-inhibitors-serotonin-noradrenaline-reuptake-inhibitors
Human,Lansopon 15 mg and 30 mg,Lansoprazole,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/308522/05,,,,,,,,23/06/2005,15/09/2005,13/10/2005,13/10/2005,https://www.ema.europa.eu/en/medicines/human/referrals/lansopon-15-mg-30-mg
Human,Lansoprazol HEXAL 15 mg and 30 mg,Lansoprazole,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/308176/05,,,,,,,,23/06/2005,15/09/2005,15/09/2005,15/09/2005,https://www.ema.europa.eu/en/medicines/human/referrals/lansoprazol-hexal-15-mg-30-mg
Human,Crestor 5 mg,rosuvastatin calcium,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/145829/05,,,,,,,,21/04/2005,09/08/2005,09/08/2005,09/08/2005,https://www.ema.europa.eu/en/medicines/human/referrals/crestor-5-mg
Human,Calcium Sandoz,Calcium lactate gluconate;Calcium carbonate,European Commission final decision,No,Article 30 referrals,,,,CHMP/289490/05,,,,,,,,21/04/2005,09/08/2005,09/08/2005,09/08/2005,https://www.ema.europa.eu/en/medicines/human/referrals/calcium-sandoz
Human,Rigevidon,levonorgestrel;ethinylestradiol,European Commission final decision,No,Article 29(4) referrals,,,,CHMP/94618/05,,,,,,,,21/01/2005,10/05/2005,08/06/2005,08/06/2005,https://www.ema.europa.eu/en/medicines/human/referrals/rigevidon
Human,Lopid,gemfibrozil,European Commission final decision,No,Article 30 referrals,,,,CHMP/289490/05,,,,,,,,24/03/2004,29/07/2004,18/08/2004,18/08/2004,https://www.ema.europa.eu/en/medicines/human/referrals/lopid
Human,Zestril,lisinopril,European Commission final decision,No,Article 30 referrals,,,,CPMP/423/04,,,,,,,,25/09/2003,16/01/2004,09/08/2004,09/08/2004,https://www.ema.europa.eu/en/medicines/human/referrals/zestril
Human,Loratadine and pseudoephedrine,loratadine;pseudoephedrine,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/4060/03,,,,,,,,21/11/2003,28/04/2004,14/07/2004,14/07/2004,https://www.ema.europa.eu/en/medicines/human/referrals/loratadine-pseudoephedrine
Human,Loratadine,loratadine,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/1333/03,,,,,,,,21/11/2003,28/04/2004,14/07/2004,14/07/2004,https://www.ema.europa.eu/en/medicines/human/referrals/loratadine
Human,Amlodipin Woerwag,amlodipine,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/538/04,,,,,,,,21/01/2004,27/04/2004,30/06/2004,30/06/2004,https://www.ema.europa.eu/en/medicines/human/referrals/amlodipin-woerwag
Human,Talam,amlodipine,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/540/04,,,,,,,,21/01/2004,27/04/2004,30/06/2004,30/06/2004,https://www.ema.europa.eu/en/medicines/human/referrals/talam
Human,Zocord,simvastatin,European Commission final decision,No,Article 30 referrals,,,,CPMP/459/04,,,,,,,,22/01/2004,28/04/2004,09/06/2004,09/06/2004,https://www.ema.europa.eu/en/medicines/human/referrals/zocord
Human,Etoricoxib,etoricoxib,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/1748/04,,,,,,,,27/02/2004,28/04/2004,09/06/2004,09/06/2004,https://www.ema.europa.eu/en/medicines/human/referrals/etoricoxib-1
Human,Rofecoxib,rofecoxib,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/1749/04,,,,,,,,21/11/2003,28/04/2004,09/06/2004,09/06/2004,https://www.ema.europa.eu/en/medicines/human/referrals/rofecoxib
Human,Celecoxib,celecoxib,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/1747/04,,,,,,,,21/11/2003,29/04/2004,09/06/2004,09/06/2004,https://www.ema.europa.eu/en/medicines/human/referrals/celecoxib-0
Human,Nimesulide,nimesulide,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/1724/04,,,,,,,,18/12/2003,26/04/2004,13/05/2004,13/05/2004,https://www.ema.europa.eu/en/medicines/human/referrals/nimesulide-0
Human,Pravachol,pravastatin,European Commission final decision,No,Article 30 referrals,,,,CPMP/6214/03,,,,,,,,21/11/2003,02/03/2004,13/05/2004,13/05/2004,https://www.ema.europa.eu/en/medicines/human/referrals/pravachol
Human,Pidolma,amlodipine,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/3122/04,,,,,,,,21/01/2004,27/04/2004,27/04/2004,27/04/2004,https://www.ema.europa.eu/en/medicines/human/referrals/pidolma
Human,Amlovita,amlodipine,European Commission final decision,No,Article 29(4) referrals,,,,EMEA/CPMP/539/04,,,,,,,,21/01/2004,26/04/2004,26/04/2004,26/04/2004,https://www.ema.europa.eu/en/medicines/human/referrals/amlovita
Human,Calcitonins,calcitonin,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/867/04,,,,,,,,22/11/2002,12/06/2003,02/03/2004,02/03/2004,https://www.ema.europa.eu/en/medicines/human/referrals/calcitonins
Human,Laurina,desogestrel;ethinyl estradiol,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CPMP/1390/04,,,,,,,,25/09/2003,05/02/2004,01/03/2004,01/03/2004,https://www.ema.europa.eu/en/medicines/human/referrals/laurina
Human,"Fluconazol Tiefenbacher 50mg, 100mg, 150mg, 200mg capsules, hard",fluconazole,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/6236/04,,,,,,,,24/07/2003,01/12/2003,11/02/2004,11/02/2004,https://www.ema.europa.eu/en/medicines/human/referrals/fluconazol-tiefenbacher-50mg-100mg-150mg-200mg-capsules-hard
Human,Calcichew D3 mite,calcium;colecalciferol,European Commission final decision,No,Article 30 referrals,,,,CPMP/3258/03,,,,,,,,26/06/2003,01/12/2003,21/01/2004,21/01/2004,https://www.ema.europa.eu/en/medicines/human/referrals/calcichew-d3-mite
Human,Calcichew D3,colecalciferol;calcium,European Commission final decision,No,Article 30 referrals,,,,CPMP/3257/03,,,,,,,,26/06/2003,01/12/2003,21/01/2004,21/01/2004,https://www.ema.europa.eu/en/medicines/human/referrals/calcichew-d3
Human,Calcitugg,Calcium carbonate,European Commission final decision,No,Article 30 referrals,,,,CPMP/3256/03,,,,,,,,26/06/2003,01/12/2003,21/01/2004,21/01/2004,https://www.ema.europa.eu/en/medicines/human/referrals/calcitugg
Human,Coversyl,perindopril,European Commission final decision,No,Article 30 referrals,,,-,CPMP/32703/03,,,,,,,,24/07/2003,04/12/2003,23/12/2003,23/12/2003,https://www.ema.europa.eu/en/medicines/human/referrals/coversyl-0
Human,Renitec,enalapril,European Commission final decision,No,Article 30 referrals,,,-,CPMP/3175/03,,,,,,,,19/09/2002,21/05/2003,02/12/2003,02/12/2003,https://www.ema.europa.eu/en/medicines/human/referrals/renitec
Human,Roaccutane,isotretinoin,European Commission final decision,No,Article 30 referrals,,,,CPMP/2846/03,,,,,,,,25/04/2003,17/10/2003,02/12/2003,02/12/2003,https://www.ema.europa.eu/en/medicines/human/referrals/roaccutane
Human,Isotretinoin,isotretinoin,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/2811/03,,,,,,,,25/04/2003,17/10/2003,02/12/2003,02/12/2003,https://www.ema.europa.eu/en/medicines/human/referrals/isotretinoin
Human,Botox,Clostridium botulinum type A neurotoxin complex,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/4260/03,,,,,,,,21/02/2003,25/06/2003,16/10/2003,16/10/2003,https://www.ema.europa.eu/en/medicines/human/referrals/botox
Human,Lisinopril Biochemie,lisinopril,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CPMP/886/04/Final,,,,,,,,24/07/2003,23/02/2004,01/09/2003,01/09/2003,https://www.ema.europa.eu/en/medicines/human/referrals/lisinopril-biochemie
Human,Norditropin,somatropin,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CPMP/3478/03,,,,,,,,20/03/2003,,29/08/2003,29/08/2003,https://www.ema.europa.eu/en/medicines/human/referrals/norditropin
Human,Genotropin,somatropin,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CPMP/3477/03,,,,,,,,20/03/2003,26/06/2003,29/08/2003,29/08/2003,https://www.ema.europa.eu/en/medicines/human/referrals/genotropin
Human,Lederfoline,calcium folinate,European Commission final decision,No,Article 30 referrals,,,,CPMP/3736/03,,,,,,,,20/03/2003,30/06/2003,14/08/2003,14/08/2003,https://www.ema.europa.eu/en/medicines/human/referrals/lederfoline
Human,Salmeterol and Fluticasone Propionate,salmeterol;fluticasone,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,-,Salmeterol and fluticasone,,,,,,,,24/01/2003,21/05/2003,31/07/2003,31/07/2003,https://www.ema.europa.eu/en/medicines/human/referrals/salmeterol-fluticasone-propionate
Human,Prozac,fluoxetine,European Commission final decision,No,Article 30 referrals,,,,CPMP/3263/03,,,,,,,,19/09/2002,,18/06/2003,18/06/2003,https://www.ema.europa.eu/en/medicines/human/referrals/prozac-0
Human,Cardiostad,lisinopril,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CPMP/869/04,,,,,,,,24/07/2003,23/02/2004,01/03/2003,01/03/2003,https://www.ema.europa.eu/en/medicines/human/referrals/cardiostad
Human,Cerivastatin,cerivastatin,European Commission final decision,No,Article 36 referrals (prior to July 2012),,,,CPMP/3962/02,,,,,,,,21/03/2002,22/08/2002,20/12/2002,20/12/2002,https://www.ema.europa.eu/en/medicines/human/referrals/cerivastatin
Human,Sibutramine,,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/4514/02,,,,,,,,27/06/2002,26/03/2001,13/12/2002,13/12/2002,https://www.ema.europa.eu/en/medicines/human/referrals/sibutramine-0
Human,Bupropion hydrochloride,bupropion,European Commission final decision,No,Article 36 referrals (prior to July 2012),,,,CPMP/2852/02,,,,,,,,25/07/2002,25/10/2002,06/12/2002,06/12/2002,https://www.ema.europa.eu/en/medicines/human/referrals/bupropion-hydrochloride
Human,Leponex,clozapine,European Commission final decision,No,Article 30 referrals,,,,CPMP/6034/02,,,,,,,,02/08/2002,12/11/2002,27/11/2002,27/11/2002,https://www.ema.europa.eu/en/medicines/human/referrals/leponex
Human,Cisapride,cisapride,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/24844/02,,,,,,,,13/12/2001,30/05/2002,29/10/2002,29/10/2002,https://www.ema.europa.eu/en/medicines/human/referrals/cisapride
Human,Motilium,domperidone,European Commission final decision,No,Article 30 referrals,,,,CPMP/4786/02,,,,,,,,27/06/2002,17/10/2002,17/10/2002,17/10/2002,https://www.ema.europa.eu/en/medicines/human/referrals/motilium
Human,Ecazide,captopril;hydrochlorothiazide,European Commission final decision,No,Article 30 referrals,,,-,CPMP/4717/02,,,,,,,,25/04/2002,22/08/2002,19/09/2002,19/09/2002,https://www.ema.europa.eu/en/medicines/human/referrals/ecazide
Human,Sertindole,sertindole,European Commission final decision,No,Article 36 referrals (prior to July 2012),,,,CPMP/2852/02,,,,,,,,20/10/2000,20/01/2000,19/09/2002,19/09/2002,https://www.ema.europa.eu/en/medicines/human/referrals/sertindole
Human,Dacarbazine Faulding,dacarbazine,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/2020/02,,,,,,,,25/04/2002,21/08/2002,19/09/2002,19/09/2002,https://www.ema.europa.eu/en/medicines/human/referrals/dacarbazine-faulding
Human,Hypnovel,midazolam,European Commission final decision,No,Article 30 referrals,,,,CPMP/4620/02,,,,,,,,22/02/2002,26/06/2002,16/09/2002,16/09/2002,https://www.ema.europa.eu/en/medicines/human/referrals/hypnovel
Human,Floxyfral,fluvoxamine,European Commission final decision,No,Article 30 referrals,,,-,CPMP/600/02,,,,,,,,18/01/2002,30/05/2002,25/07/2002,25/07/2002,https://www.ema.europa.eu/en/medicines/human/referrals/floxyfral
Human,Glucophage/Glucophage Forte/Risidon/Dianben,metformin,European Commission final decision,No,Article 30 referrals,,,,CPMP/4082/00,,,,,,,,19/10/2000,06/02/2001,07/02/2001,07/02/2001,https://www.ema.europa.eu/en/medicines/human/referrals/glucophage-glucophage-forte-risidon-dianben
Human,Ketoprofene Ethypharm LP,ketoprofen,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/1988/00,,,,,,,,29/06/2000,27/12/2000,28/12/2000,28/12/2000,https://www.ema.europa.eu/en/medicines/human/referrals/ketoprofene-ethypharm-lp
Human,MultiHance,gadobenic acid,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CPMP/1361/00,,,,,,,,25/05/2000,15/09/2000,15/12/2000,15/12/2000,https://www.ema.europa.eu/en/medicines/human/referrals/multihance
Human,"Zofenil, Zopranol, Bifril",zofenopril,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CPMP/2011/00,,,,,,,,27/07/2000,29/11/2000,29/11/2000,29/11/2000,https://www.ema.europa.eu/en/medicines/human/referrals/zofenil-zopranol-bifril
Human,"Bifril, Teoula, Zofepril, Zopranol",zofenopril,European Commission final decision,No,Article 6(12) referrals (prior to January 2010),,,,CPMP/4362/00,,,,,,,,27/07/2000,29/11/2000,29/11/2000,29/11/2000,https://www.ema.europa.eu/en/medicines/human/referrals/bifril-teoula-zofepril-zopranol
Human,Engerix B,"hepatitis B recombinant vaccine, adsorbed",European Commission final decision,No,Article 30 referrals,,,,CPMP/1493/01,,,,,,,,13/04/2000,28/08/2000,28/08/2000,28/08/2000,https://www.ema.europa.eu/en/medicines/human/referrals/engerix-b
Human,Cyklo-f,tranexamic acid,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/902/00,,,,,,,,25/05/2000,12/09/2000,27/07/2000,27/07/2000,https://www.ema.europa.eu/en/medicines/human/referrals/cyklo-f
Human,Aggrastat,Tirofiban,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/990/99,,,,,,,,26/03/1999,18/06/1999,18/06/1999,18/06/1999,https://www.ema.europa.eu/en/medicines/human/referrals/aggrastat
Human,Vigabatrin,vigabatrin,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/1357/99,,,,,,,,20/05/1999,05/10/1999,12/10/1998,12/10/1998,https://www.ema.europa.eu/en/medicines/human/referrals/vigabatrin
Human,Amaryl,glimepiride,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/1416/98,,,,,,,,17/04/1996,29/08/1996,03/08/1998,03/08/1998,https://www.ema.europa.eu/en/medicines/human/referrals/amaryl
Human,Mizollen,mizalostine,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/1500/98,,,,,,,,19/12/1996,01/04/1997,03/08/1998,03/08/1998,https://www.ema.europa.eu/en/medicines/human/referrals/mizollen
Human,Fluoxetin NM,fluoxetine,European Commission final decision,No,Article 29(4) referrals,,,,CPMP/1154/98,,,,,,,,18/12/1997,09/06/1998,19/06/1998,19/06/1998,https://www.ema.europa.eu/en/medicines/human/referrals/fluoxetin-nm
Human,Terfenadine,terfenadine,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/34168/98,,,,,,,,20/11/1997,22/09/1998,22/01/1998,22/01/1998,https://www.ema.europa.eu/en/medicines/human/referrals/terfenadine
Human,Chlormezanone,chlormezanone,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/375/97,,,,,,,,23/01/1997,27/08/1997,22/09/1997,22/09/1997,https://www.ema.europa.eu/en/medicines/human/referrals/chlormezanone
Human,Anorectics,phentermine;amfepramome;clobenzorex;dexfenfluramine;fenbutrazate;fenfluramine;fenproporex;mazindol;mefenorex;norpseudoephedrine;phenmetrazine;phendimetrazine;propylhexedrine,European Commission final decision,Yes,Article 31 referrals,,,Anorectics,"CPMP/101-109/96, CPMP/111-112/96, CPMP/113-114/96",,,,,,,,16/02/1996,09/12/1996,10/12/1996,10/12/1996,https://www.ema.europa.eu/en/medicines/human/referrals/anorectics
Human,Naftidrofuryl,naftidrofuryl,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/578/95,,,,,,,,19/10/1995,26/06/1996,26/06/1996,26/06/1996,https://www.ema.europa.eu/en/medicines/human/referrals/naftidrofuryl
Human,Zagam,sparfloxacin,European Commission final decision,Yes,Article 31 referrals,,,,CPMP/931/95,,,,,,,,19/12/1995,,06/05/1996,06/05/1996,https://www.ema.europa.eu/en/medicines/human/referrals/zagam
